Unnamed: 0,title,date,stock,sentiment
641957.0,UPDATE: Horizon Therapeutics' KRYSTEXXA MIRROR Open-Label Trial Shows 79% Of Patients Achieved Complete Response,2020-06-03 08:24:00-04:00,HZNP,neutral
641958.0,Data Presented on KRYSTEXXAÂ® (pegloticase injection) Co-Prescribed with an Immunomodulator Adds to Growing Body of Evidence for this Treatment Approach,2020-06-03 08:17:00-04:00,HZNP,positive
641959.0,Stocks That Hit 52-Week Highs On Friday,2020-05-29 10:36:00-04:00,HZNP,neutral
641960.0,"The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas",2020-05-27 07:25:00-04:00,HZNP,positive
641961.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-26 10:32:00-04:00,HZNP,neutral
641962.0,"B of A Securities Reiterates Buy on Horizon Therapeutics, Raises Price Target to $57",2020-05-26 08:21:00-04:00,HZNP,positive
641963.0,Stocks That Hit 52-Week Highs On Friday,2020-05-22 10:31:00-04:00,HZNP,neutral
641964.0,"The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray",2020-05-22 07:10:00-04:00,HZNP,neutral
641965.0,Stocks That Hit 52-Week Highs On Thursday,2020-05-21 10:25:00-04:00,HZNP,neutral
641966.0,Horizon Therapeutics To Present Data On KRYSTEXXA At European Congress Of Rheumatology,2020-05-21 08:07:00-04:00,HZNP,neutral
641967.0,"In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs",2020-05-19 09:38:00-04:00,HZNP,positive
641968.0,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",2020-05-19 08:24:00-04:00,HZNP,positive
641969.0,Stocks That Hit 52-Week Highs On Monday,2020-05-18 10:44:00-04:00,HZNP,neutral
641970.0,Horizon Therapeutics To Present New Data On Pharmacokinetic Profile Of TEPEZZA,2020-05-14 09:08:00-04:00,HZNP,neutral
641971.0,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter",2020-05-13 07:40:00-04:00,HZNP,neutral
641972.0,Horizon Pharma Shares Volatile On Volume Spike; Hearing CEO To Appear On CNBC Shortly,2020-05-12 14:32:00-04:00,HZNP,positive
641973.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,HZNP,negative
641974.0,Stocks That Hit 52-Week Highs On Monday,2020-05-11 10:28:00-04:00,HZNP,neutral
641975.0,"Morgan Stanley Maintains Overweight on Horizon Therapeutics, Raises Price Target to $50",2020-05-08 07:30:00-04:00,HZNP,negative
641976.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,HZNP,negative
641977.0,66 Biggest Movers From Yesterday,2020-05-07 05:52:00-04:00,HZNP,neutral
641978.0,58 Stocks Moving In Wednesday's Mid-Day Session,2020-05-06 13:19:00-04:00,HZNP,neutral
641979.0,Stocks That Hit 52-Week Highs On Wednesday,2020-05-06 10:43:00-04:00,HZNP,neutral
641980.0,Horizon Therapeutics shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-05-06 09:59:00-04:00,HZNP,positive
641981.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,HZNP,positive
641982.0,19 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-05-06 07:36:00-04:00,HZNP,neutral
641983.0,Horizon Therapeutics Raises FY20 Sales Guidance From $1.40B-$1.42B To $1.40B-$1.45B vs $1.35B Est.,2020-05-06 07:26:00-04:00,HZNP,neutral
641984.0,"Horizon Therapeutics Q1 Adj. EPS $0.400 Beats $0.210 Estimate, Sales $355.900M Beat $287.880M Estimate",2020-05-06 07:24:00-04:00,HZNP,neutral
641985.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,HZNP,neutral
641986.0,"Jefferies Maintains Buy on Horizon Therapeutics, Raises Price Target to $51",2020-04-28 08:43:00-04:00,HZNP,neutral
641987.0,Horizon Therapeutics Announces Availability Of PROCYSBI Delayed-Release Oral Granules In Packets In The United States,2020-04-27 08:12:00-04:00,HZNP,positive
641988.0,"Piper Sandler Maintains Overweight on Horizon Therapeutics, Lowers Price Target to $44",2020-04-14 08:43:00-04:00,HZNP,negative
641989.0,"Morgan Stanley Maintains Overweight on Horizon Therapeutics, Lowers Price Target to $39",2020-04-02 09:18:00-04:00,HZNP,negative
641990.0,"Horizon Therapeutics plc Acquires Curzion Pharmaceuticals, Inc. And Its LPAR1 Antagonist Product Candidate For $45M Upfront In Cash And Additional Payments Contingent Upon Milestones",2020-04-02 08:27:00-04:00,HZNP,negative
641991.0,Horizon Therapeutics Shares Quiet Following Co. Press Release Highlighting Co.'s TEPEZZA 'Significanctly' Reduces Proptosis Across Patient Subtypes,2020-03-31 12:02:00-04:00,HZNP,positive
641992.0,"B of A Securities Maintains Buy on Horizon Therapeutics, Lowers Price Target to $42",2020-03-23 08:47:00-04:00,HZNP,positive
641993.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,HZNP,negative
641994.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",2020-02-26 09:36:00-05:00,HZNP,negative
641995.0,Horizon Therapeutics PLC shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY20 sales guidance above analyst estimates.,2020-02-26 09:17:00-05:00,HZNP,positive
641996.0,Horizon Therapeutics Sees FY20 Sales $1.40B-$1.42B vs $1.39B Est.,2020-02-26 07:29:00-05:00,HZNP,neutral
641997.0,"Horizon Therapeutics Q4 EPS $0.56 Beats $0.43 Estimate, Sales $363.545M Beat $349.24M Estimate",2020-02-26 07:28:00-05:00,HZNP,neutral
641998.0,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,2020-02-23 18:38:00-05:00,HZNP,neutral
641999.0,Horizon Therapeutics Reports FDA Approval Of New Dosage Form For PROCYSBI Delayed-Release Oral Granules,2020-02-18 08:13:00-05:00,HZNP,positive
642000.0,Horizon Therapeutics plc Announces FDA Approval Of New Dosage Form For PROCYSBI Delayed-Release Oral Granules,2020-02-18 08:01:00-05:00,HZNP,positive
642001.0,Horizon Therapeutics Announces It Will Purchase Three-Building Campus In Deerfield; Terms Not Disclosed.,2020-01-28 11:13:00-05:00,HZNP,neutral
642002.0,"The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes",2020-01-26 10:23:00-05:00,HZNP,neutral
642003.0,"The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment",2020-01-23 07:24:00-05:00,HZNP,positive
642004.0,"BMO Capital Maintains Outperform on Horizon Therapeutics, Raises Price Target to $46",2020-01-22 10:21:00-05:00,HZNP,neutral
642005.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-22 10:17:00-05:00,HZNP,neutral
642006.0,"The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings",2020-01-22 08:25:00-05:00,HZNP,neutral
642007.0,Hearing FDA Approves Horizon Therapeutics Thyroid Eye Disease Treatment,2020-01-21 14:51:00-05:00,HZNP,positive
642008.0,"The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics",2020-01-16 07:22:00-05:00,HZNP,neutral
642009.0,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug",2020-01-14 07:55:00-05:00,HZNP,positive
642010.0,"Horizon Therapeutics Announces 79% Of Patients Achieved A Complete Response In MIRROR Open-Label Pilot Study, Supporting KRYSTEXXA Immunomodulation Strategy To Optimize Treatment Outcomes",2020-01-13 08:22:00-05:00,HZNP,positive
642011.0,Horizon Therapeutics Raises Prelim. FY19 KRYSTEXXA Sales Guidance From $750M To $1B+,2020-01-13 08:20:00-05:00,HZNP,neutral
642012.0,"Goldman Sachs Initiates Coverage On Horizon Therapeutics with Neutral Rating, Announces $35 Price Target",2020-01-08 06:41:00-05:00,HZNP,neutral
642013.0,"The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping",2019-12-27 07:59:00-05:00,HZNP,neutral
642014.0,"The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares",2019-12-26 07:55:00-05:00,HZNP,negative
642015.0,"The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict",2019-12-24 07:24:00-05:00,HZNP,negative
642016.0,Stocks That Hit 52-Week Highs On Friday,2019-12-20 11:59:00-05:00,HZNP,neutral
642017.0,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering",2019-12-20 08:12:00-05:00,HZNP,positive
642018.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-19 10:29:00-05:00,HZNP,neutral
642019.0,"The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",2019-12-19 07:52:00-05:00,HZNP,negative
642020.0,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",2019-12-18 07:23:00-05:00,HZNP,positive
642021.0,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",2019-12-17 07:56:00-05:00,HZNP,positive
642022.0,UPDATE: Morgan Stanley On Horizon Therapeutics Thinks 'that the set up for HZNP remains encouraging entering 2020 given upward pressure on teprotumumab and Krystexxa sales and improving business mix',2019-12-16 12:44:00-05:00,HZNP,positive
642023.0,"UPDATE: Morgan Stanley Reiterates Overweight On Horizon Therapeutics, Raises Target To $38 'Following the Dec. 13 unanimous FDA panel meeting in favor of tepro approval'",2019-12-16 12:44:00-05:00,HZNP,positive
642024.0,"Stifel Nicolaus Maintains Buy on Horizon Therapeutics, Raises Price Target to $40",2019-12-16 09:52:00-05:00,HZNP,neutral
642025.0,"BMO Capital Maintains Outperform on Horizon Therapeutics, Raises Price Target to $40",2019-12-16 09:39:00-05:00,HZNP,neutral
642026.0,"Morgan Stanley Maintains Overweight on Horizon Therapeutics, Raises Price Target to $38",2019-12-16 08:34:00-05:00,HZNP,negative
642027.0,"Stifel Maintains Buy on Horizon Therapeutics, Raises Price Target to $40",2019-12-16 07:59:00-05:00,HZNP,neutral
642028.0,A Peek Into The Markets: US Stock Futures Up Ahead Of Economic Data,2019-12-16 06:16:00-05:00,HZNP,neutral
642029.0,"5 Stocks To Watch For December 16, 2019",2019-12-16 05:46:00-05:00,HZNP,neutral
642030.0,Horizon Therapeutics Says FDA Advisory Committee Has Voted Unanimously To Support Use Of Teprotumumab For Thyroid Eye Disease,2019-12-13 16:02:00-05:00,HZNP,positive
642031.0,Horizon Shares Halted Ahead Of FDA Dermatologic and Ophthalmic Drugs Advisory Committee Meeting To Discuss Teprotumumab For Thyroid Eye Disease; Meeting Runs From 8 a.m. To 4 p.m. EST,2019-12-13 07:00:00-05:00,HZNP,positive
642032.0,Horizon Pharma Shares Halted News Pending,2019-12-13 06:56:00-05:00,HZNP,positive
642033.0,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",2019-11-27 07:26:00-05:00,HZNP,negative
642034.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-26 11:03:00-05:00,HZNP,neutral
642035.0,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",2019-11-26 08:06:00-05:00,HZNP,positive
642036.0,Stocks That Hit 52-Week Highs On Monday,2019-11-25 10:19:00-05:00,HZNP,neutral
642037.0,Stocks That Hit 52-Week Highs On Friday,2019-11-22 10:17:00-05:00,HZNP,neutral
642038.0,"The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon",2019-11-21 07:22:00-05:00,HZNP,positive
642039.0,Stocks That Hit 52-Week Highs On Wednesday,2019-11-20 10:12:00-05:00,HZNP,neutral
642040.0,Stocks That Hit 52-Week Highs On Wednesday,2019-11-06 10:10:00-05:00,HZNP,neutral
642041.0,"The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings",2019-11-06 08:21:00-05:00,HZNP,positive
642042.0,"Horizon Therapeutics Reaffirms FY19 Sales Guidance $1.28B-$1.3B vs $1.28B Estimate, Raises Adj. EBITDA Guidance To $465M-$475M",2019-11-06 08:13:00-05:00,HZNP,neutral
642043.0,"Horizon Therapeutics Q3 EPS $0.64 Beats $0.49 Estimate, Sales $335.466M Beat $329.76M Estimate",2019-11-06 08:12:00-05:00,HZNP,neutral
642044.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-05 11:12:00-05:00,HZNP,neutral
642045.0,"The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment",2019-11-05 06:53:00-05:00,HZNP,negative
642046.0,Stocks That Hit 52-Week Highs On Monday,2019-11-04 14:43:00-05:00,HZNP,neutral
642047.0,Horizon Therapeutics to Present an Integrated Analysis of Efficacy Data From Phase 2 and 3 Trials of Teprotumumab During the American College of Rheumatology Annual Meeting,2019-11-04 08:32:00-05:00,HZNP,neutral
642048.0,"The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight",2019-11-03 10:51:00-05:00,HZNP,neutral
642049.0,"Horizon Therapeutics Reports Data From Phase 2, Phase 3 Trial Of Teprotumumab For Treatment Of Active Thyroid Eye Disease vs Placebo",2019-10-31 10:03:00-04:00,HZNP,positive
642050.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,HZNP,negative
642051.0,Stocks That Hit 52-Week Highs On Tuesday,2019-10-29 10:52:00-04:00,HZNP,neutral
642052.0,Horizon Therapeutics To Present New Combined Data From Phase 2 And Phase 3 Teprotumumab Clinical Trials At  American Thyroid Association Annual Meeting,2019-10-24 08:14:00-04:00,HZNP,neutral
642053.0,Horizon Therapeutics Initiates PROTECT Trial Evaluating KRYSTEXXA To Improve Management Of Uncontrolled Gout For Adults With Kidney Transplant,2019-10-17 08:01:00-04:00,HZNP,positive
642054.0,4 Stocks Nearing Key Breakouts,2019-10-16 11:51:00-04:00,HZNP,neutral
642055.0,"UPDATE: Bank Of America Initiates Horizon Therapeutics With Buy, $34 Target As Firm's Thesis Is Driven By 'tepro approval and favorable payer coverage for TED', 'Krystexxa (gout) continued execution of re-launch and read-across to tepro launch hurdles'",2019-09-26 14:05:00-04:00,HZNP,positive
642056.0,"Benzinga's Top Upgrades, Downgrades For September 26, 2019",2019-09-26 09:40:00-04:00,HZNP,positive
642057.0,"Bank of America Initiates Coverage On Horizon Therapeutics with Buy Rating, Announces $34 Price Target",2019-09-26 07:37:00-04:00,HZNP,neutral
642058.0,Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival.,2019-09-20 13:00:00-04:00,HZNP,negative
642059.0,"UPDATE: Guggenheim On Horizon Also Notes Potential Catalysts: 'Teprotumumab PDUFA / launch (1Q20), SELB data vs. KKX (4Q19-1Q20), KKX kidney transplant and methotrexate data (2021)'",2019-09-12 11:32:00-04:00,HZNP,neutral
642060.0,"UPDATE: Guggenheim Initiates Horizon With Buy, $36 Target As Firm Believes Co. Is 'EV-103 data at ESMO could hint at larger opportunity in bladder cancer'; Sees 'upside to estimates on Krystexxa /Teprotumumab top line growth (we are modestly above cons.)'",2019-09-12 11:31:00-04:00,HZNP,positive
642061.0,"Benzinga's Top Upgrades, Downgrades For September 12, 2019",2019-09-12 09:32:00-04:00,HZNP,positive
642062.0,"Guggenheim Initiates Coverage On Horizon Therapeutics with Buy Rating, Announces $36 Price Target",2019-09-12 06:57:00-04:00,HZNP,neutral
642063.0,Horizon Therapeutics Announces FDA Has Granted Priority Review To Teprotumumab Biologics License Application For The Treatment Of Active Thyroid Eye Disease,2019-09-09 08:10:00-04:00,HZNP,positive
642064.0,"Horizon Therapeutics Has 'Headroom For Value Creation,' BMO Says In Upgrade",2019-08-14 10:47:00-04:00,HZNP,positive
642065.0,"Benzinga's Top Upgrades, Downgrades For August 14, 2019",2019-08-14 10:00:00-04:00,HZNP,positive
642066.0,10 Biggest Price Target Changes For Wednesday,2019-08-14 09:11:00-04:00,HZNP,neutral
642067.0,"BMO Capital Upgrades Horizon Therapeutics to Outperform, Raises Price Target to $36",2019-08-14 07:26:00-04:00,HZNP,neutral
642068.0,Horizon Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 sales guidance above analyst estimates.,2019-08-07 09:06:00-04:00,HZNP,positive
642069.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,HZNP,neutral
642070.0,Horizon Therapeutics Raises FY19 Sales Guidance From $1.26B-$1.28B To $1.28B-$1.30B vs $1.26B Est.,2019-08-07 07:11:00-04:00,HZNP,neutral
642071.0,"Horizon Therapeutics Q2 Adj. EPS $0.49 Beats $0.37 Estimate, Sales $320.6M Beat $297.07M Estimate",2019-08-07 07:10:00-04:00,HZNP,neutral
642072.0,Horizon Therapeutics Reports Teprotumumab Expanded Access Program,2019-08-01 10:49:00-04:00,HZNP,neutral
642073.0,Horizon Therapeutics Announces Court Of Appeals Denied Company's Request For A Rehearing Of Court's Invalidity Ruling Against Patents For Vimovo Tablets,2019-07-30 11:28:00-04:00,HZNP,negative
642074.0,Horizon Therapeutics Reports FDA Acceptance Of New Drug Application to Make PROCYSBI Available As Oral Granules In Packets,2019-07-18 09:00:00-04:00,HZNP,positive
642075.0,Horizon Therapeutics plc Submits Teprotumumab Biologics License Application (BLA) For Treatment Of Active Thyroid Eye Disease (TED),2019-07-10 07:07:00-04:00,HZNP,positive
642076.0,"Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs.",2019-07-08 12:55:00-04:00,HZNP,positive
642077.0,Shares of multiple drugmakers and biotech companies are trading higher after AbbVie announced it will acquire Allergan.,2019-06-25 11:21:00-04:00,HZNP,positive
642078.0,Horizon Therapeutics Initiates MIRROR Randomized Controlled Trial Evaluating KRYSTEXXA In Combination With Methotrexate To Increase Response Rates And Duration Of Therapy,2019-06-20 08:02:00-04:00,HZNP,positive
642079.0,Shares of several companies in the biotech space are trading higher after Pfizer announced it will acquire Array BioPharma.,2019-06-17 10:10:00-04:00,HZNP,positive
642080.0,Horizon Therapeutics plc And Invitae Corporation Launch Urea Cycle Disorder Genetic Testing Program,2019-05-29 08:15:00-04:00,HZNP,negative
642081.0,"Horizon Therapeutics Shares Dip Lower, Quickly Rebound From Session Low; Hearing Co. Has Lost Appeal Over 2 Patents On Vimovo Pain Drug",2019-05-15 09:56:00-04:00,HZNP,negative
642082.0,"Shares of several healthcare companies are trading lower amid continued trade dispute between the US and China. Also, the United States filed a lawsuit against drug manufacturers alleging price fixing.",2019-05-13 10:35:00-04:00,HZNP,negative
642083.0,"The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split",2019-05-08 07:53:00-04:00,HZNP,negative
642084.0,Horizon Pharma Raises FY19 Sales Guidance From $1.23B-$1.25B To $1.26B-$1.28B vs $1.24B Est.,2019-05-08 07:20:00-04:00,HZNP,neutral
642085.0,"Horizon Pharma Q1 EPS $0.3 Up From $0.03 YoY, Sales $280.4M Up From $223.881M YoY",2019-05-08 07:18:00-04:00,HZNP,neutral
642086.0,"Benzinga's Top Upgrades, Downgrades For May 1, 2019",2019-05-01 09:24:00-04:00,HZNP,positive
642087.0,Horizon Pharma shares are trading higher after Citigroup upgraded the stock from Neutral to Buy and raised the price target from $21 to $32.,2019-05-01 08:59:00-04:00,HZNP,positive
642088.0,"Citigroup Upgrades Horizon Pharma plc - common stock to Buy, Raises Price Target to $32",2019-05-01 07:45:00-04:00,HZNP,neutral
642089.0,Citigroup Upgrades Horizon Pharma plc - common stock to Buy,2019-05-01 06:52:00-04:00,HZNP,neutral
642090.0,"The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug",2019-04-26 08:02:00-04:00,HZNP,negative
642091.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs",2019-04-21 14:06:00-04:00,HZNP,neutral
642092.0,50 Stocks Moving In Friday's Mid-Day Session,2019-03-08 12:31:00-05:00,HZNP,neutral
642093.0,UPDATE: Morgan Stanley Upgrades Horizon Pharma As Firm Believes 'the market undervalues HZNP ahead of its mix shift to orphan/rheum diseases',2019-03-08 10:41:00-05:00,HZNP,neutral
642094.0,"Benzinga's Top Upgrades, Downgrades For March 8, 2019",2019-03-08 09:04:00-05:00,HZNP,positive
642095.0,28 Stocks Moving In Friday's Pre-Market Session,2019-03-08 07:54:00-05:00,HZNP,neutral
642096.0,Morgan Stanley Upgrades Horizon Pharma to Overweight,2019-03-08 06:47:00-05:00,HZNP,negative
642097.0,26 Stocks Moving In Thursday's Pre-Market Session,2019-03-07 08:01:00-05:00,HZNP,neutral
642098.0,Horizon Pharma Prices 12.244M Share Public Offering of Ordinary Shares @$24.50/Share,2019-03-07 03:44:00-05:00,HZNP,positive
642099.0,"Shares of several biotech companies are trading lower after FDA commissioner Scott Gottlieb announced he will resign; he pushed to spur the development of new drugs and with his absence, there is concern on future FDA approvals.",2019-03-06 11:59:00-05:00,HZNP,negative
642100.0,"Horizon Pharma Exec VP Geoffrey Curtis, Responding To Tues. Evening Chatter Co.'s $300M Offering Was Cancelled/Delayed, Confirms To Benzinga Co. Has Not Cancelled Its Ordinary Share Offering Announced Mon. Afternoon",2019-03-06 11:07:00-05:00,HZNP,positive
642101.0,30 Stocks Moving In Wednesday's Pre-Market Session,2019-03-06 08:00:00-05:00,HZNP,neutral
642102.0,"The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",2019-03-06 07:39:00-05:00,HZNP,negative
642103.0,IPO Boutique Reports Horizon Pharma Offering Is Being Delayed Due To Late-Breaking Information Regarding The Company,2019-03-05 17:05:00-05:00,HZNP,negative
642104.0,Hearing Horizon Pharma Has Cancelled Its $300M Offering Announced Mon. Afternoon,2019-03-05 16:23:00-05:00,HZNP,negative
642105.0,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",2019-03-05 07:24:00-05:00,HZNP,positive
642106.0,Horizon Pharma Reports $300M Ordinary Share Offering,2019-03-04 16:11:00-05:00,HZNP,positive
642107.0,"Horizon Pharma Filing Shows Registration For Ordinary Shares Offering, No Size Disclosed",2019-03-04 16:07:00-05:00,HZNP,neutral
642108.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Fri., Mar. 1, 2019",2019-03-01 08:55:00-05:00,HZNP,positive
642109.0,"The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis",2019-03-01 08:50:00-05:00,HZNP,neutral
642110.0,75 Biggest Movers From Yesterday,2019-03-01 04:55:00-05:00,HZNP,neutral
642111.0,Mid-Afternoon Market Update: Box Drops On Weak Forecast; Arcadia Biosciences Shares Gain,2019-02-28 14:30:00-05:00,HZNP,positive
642112.0,51 Stocks Moving In Thursday's Mid-Day Session,2019-02-28 12:28:00-05:00,HZNP,neutral
642113.0,Mid-Day Market Update: Veritiv Falls After Q4 Results; Horizon Pharma Shares Surge,2019-02-28 12:09:00-05:00,HZNP,positive
642114.0,Mid-Morning Market Update: Markets Open Lower; J C Penney Profit Beats Expectations,2019-02-28 10:12:00-05:00,HZNP,positive
642115.0,Horizon Pharma shares are trading higher after the company said its phase 3 trials for active thryoid eye disease treatment met primary and all secondary endpoints.,2019-02-28 08:57:00-05:00,HZNP,positive
642116.0,34 Stocks Moving In Thursday's Pre-Market Session,2019-02-28 08:26:00-05:00,HZNP,neutral
642117.0,Horizon Pharma Announces Phase 3 Confirmatory Trial Evaluating Teprotumumab (OPTIC) For Active Thyroid Eye Disease (TED) Met Primary And All Secondary Endpoints,2019-02-28 07:48:00-05:00,HZNP,positive
642118.0,Horizon Pharma Sees FY19 Sales $1.23B-$1.25B vs $1.24B Est.,2019-02-27 07:25:00-05:00,HZNP,neutral
642119.0,"Horizon Pharma Q4 Adj. EPS $0.67 Beats $0.54 Estimate, Sales $355.543M Beat $334.22M Estimate",2019-02-27 07:24:00-05:00,HZNP,neutral
642120.0,"Earnings Scheduled For February 27, 2019",2019-02-27 04:03:00-05:00,HZNP,neutral
642121.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-02-22 13:55:00-05:00,HZNP,neutral
642122.0,35 Stocks Moving In Wednesday's Pre-Market Session,2019-02-13 08:47:00-05:00,HZNP,neutral
642123.0,"Jim Cramer Shares His Thoughts On Ford, PepsiCo And More",2019-01-31 07:58:00-05:00,HZNP,positive
642124.0,"Horizon Pharma 8-K Shows Co. Sold Rights To RAVICTI, AMMONAPS Outside North America, Japan To Medical Need Europe For $35M",2019-01-04 09:08:00-05:00,HZNP,neutral
642125.0,Horizon Pharma Reports Entered Exclusive Drug Discovery Collab With HemoShear For Gout,2019-01-03 08:02:00-05:00,HZNP,positive
642126.0,Horzion Pharma Reports FDA Approval To Expand Age Range For RAVICTI Liquid To Include Newborns,2018-12-27 08:07:00-05:00,HZNP,positive
642127.0,8 Biggest Price Target Changes For Thursday,2018-11-15 09:36:00-05:00,HZNP,neutral
642128.0,"Benzinga's Top Upgrades, Downgrades For November 15, 2018",2018-11-15 09:08:00-05:00,HZNP,positive
642129.0,"Mizuho Downgrades Horizon Pharma to Neutral, Lowers Price Target to $21",2018-11-15 06:10:00-05:00,HZNP,negative
642130.0,Hearing Novartis AG Has Approached Horizon Pharma With $31/Share Takeover Bid; Unconfirmed,2018-11-14 09:51:00-05:00,HZNP,negative
642131.0,"Stocks Which Set New 52-Week High Yesterday, Wed., Nov. 7, 2018",2018-11-08 10:52:00-05:00,HZNP,neutral
642132.0,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",2018-11-08 08:10:00-05:00,HZNP,negative
642133.0,88 Biggest Movers From Yesterday,2018-11-08 04:54:00-05:00,HZNP,neutral
642134.0,Horizon Pharma Maintains FY2018 Sales of $1.17B-1.20B vs $1.18B Est,2018-11-07 08:16:00-05:00,HZNP,neutral
642135.0,"Horizon Pharma, Inc. Q3 EPS $0.65 Beats $0.50 Estimate, Sales $325.311M Beat $311.85M Estimate",2018-11-07 08:15:00-05:00,HZNP,neutral
642136.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",2018-11-07 07:50:00-05:00,HZNP,negative
642137.0,"Earnings Scheduled For November 7, 2018",2018-11-07 03:51:00-05:00,HZNP,neutral
642138.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,HZNP,neutral
642139.0,Horizon Shares Down 5.5%; Cowen Notes 2 Recent Disclosures From Co. 'with 1 of the 2 (the release of disappointing competitive data which therefore preserves and secures Krystexxa' place as the leader for years to come) far outweighing...',2018-10-23 12:28:00-04:00,HZNP,positive
642140.0,"Stocks Which Set New 52-Week High Yesterday, August 9th",2018-08-10 10:03:00-04:00,HZNP,neutral
642141.0,"The Daily Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss",2018-08-10 07:38:00-04:00,HZNP,negative
642142.0,"Stocks Which Set New 52-Week High Yesterday, August 8th",2018-08-09 11:03:00-04:00,HZNP,neutral
642143.0,"Jefferies Maintains Buy on Horizon Pharma, Raises Price Target to $23",2018-08-09 09:30:00-04:00,HZNP,neutral
642144.0,"The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings",2018-08-09 08:39:00-04:00,HZNP,positive
642145.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,HZNP,neutral
642146.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,HZNP,positive
642147.0,"Benzinga's Top Upgrades, Downgrades For August 6, 2018",2018-08-06 09:13:00-04:00,HZNP,positive
642148.0,"BMO Capital Downgrades Horizon Pharma to Market Perform, Announces $18 Price Target",2018-08-06 07:49:00-04:00,HZNP,neutral
642149.0,Clinigen Acquires Global Rights to Imukin from Horizon Pharma; Terms Not Disclosed,2018-07-25 04:15:00-04:00,HZNP,neutral
642150.0,Horizon Pharma Reports US PTO Issuance Of Added Notices Of Allowance With Claims Covering RAVICTI Oral Liquid,2018-07-16 08:31:00-04:00,HZNP,neutral
642151.0,Citigroup Downgrades Horizon Pharma to Neutral,2018-06-27 08:10:00-04:00,HZNP,neutral
642152.0,"Benzinga's Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time",2018-05-31 08:22:00-04:00,HZNP,positive
642153.0,"Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA",2018-05-30 08:14:00-04:00,HZNP,positive
642154.0,"Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway",2018-05-09 07:48:00-04:00,HZNP,neutral
642155.0,"Horizon Pharma Raises FY2018 Sales Guidance from $1.15B-1.18B to $1.17B-1.20B vs $1.15B Est., Adj. EBITDA From $370M-$395M To $390M-$415M",2018-05-09 07:24:00-04:00,HZNP,neutral
642156.0,Horizon Pharma Raises Outlook,2018-05-09 07:24:00-04:00,HZNP,neutral
642157.0,"Horizon Pharma Q1 EPS $0.03 Misses $0.07 Estimate, Sales $223.881M Miss $234.17M Estimate",2018-05-09 07:24:00-04:00,HZNP,negative
642158.0,"Earnings Scheduled For May 7, 2018",2018-05-07 04:23:00-04:00,HZNP,neutral
642159.0,"The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More",2018-05-06 18:19:00-04:00,HZNP,neutral
642160.0,Cantor Fitzgerald Names 8 Upcoming Biotech Catalysts,2018-03-13 16:32:00-04:00,HZNP,neutral
642161.0,"Height Securities Sees Regulators Changing Their Approah To Drug Pricing, Cites Horizon Pharma's KRYSTEXXA As Potential Beneficiary",2018-03-01 08:42:00-05:00,HZNP,positive
642162.0,"Horizon Pharma Sees FY18 Adj. EBITDA $370M-$395M, Sales $1.15B-$1.18B vs $1.14B Est.",2018-02-28 07:08:00-05:00,HZNP,neutral
642163.0,"Horizon Pharma Reports Q4 Adj. EPS $0.29 vs $0.22 Est., Sales $274.2M vs $264.5M Est.",2018-02-28 07:07:00-05:00,HZNP,neutral
642164.0,"Earnings Scheduled For February 28, 2018",2018-02-28 04:20:00-05:00,HZNP,neutral
642165.0,Horizon Pharma Reports Submission Of sNDA For RAVICTI Oral Liquid,2018-02-27 18:01:00-05:00,HZNP,neutral
642166.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-02-25 15:50:00-05:00,HZNP,neutral
642167.0,33 Stocks Moving In Friday's Mid-Day Session,2018-01-12 12:25:00-05:00,HZNP,neutral
642168.0,5 Biggest Price Target Changes For Friday,2018-01-12 10:11:00-05:00,HZNP,neutral
642169.0,"Benzinga's Top Upgrades, Downgrades For January 12, 2018",2018-01-12 09:26:00-05:00,HZNP,positive
642170.0,"The Market In 5 Minutes: Blockchain Enthusiasm, Facebook's News Feed, Trump's Potty Mouth",2018-01-12 09:00:00-05:00,HZNP,positive
642171.0,Mizuho Upgrades Horizon Pharma to Buy from Neutral; Raises PT to $18 from $12 -Reuters,2018-01-12 04:17:00-05:00,HZNP,neutral
642172.0,Horizon Pharma Raises Peak Net Sales Guidance From $650M To $1.5B+,2018-01-08 11:22:00-05:00,HZNP,neutral
642173.0,"Horizon Pharma Earlier Announced Licensing Global Rights To MEDI4945 From AstraZeneca, Will Provide Upfront Cash Payment And Future Milestone Payments",2018-01-08 11:01:00-05:00,HZNP,neutral
642174.0,"Several Biotechs Higher Tuesday Amid Jefferies Mention Of Price Increases In Effect; Insys +13.21%, Synergy Pharmaceuticals +6.72%, Allergan +3.22%, Horizon Pharma +0.99%, Supernus Pharma +0.25%, Teva Pharma +0.53%; Collegium An Outlier, Down 0.64%",2018-01-02 12:26:00-05:00,HZNP,neutral
642175.0,Horizon Pharma Reports FDA Approval To Expand Indication For PROCYSBI Delayed-Release Capsules To Include Children 1 Year Of Age And Older Living With Nephropathic Cystinosis,2017-12-27 08:07:00-05:00,HZNP,positive
642176.0,"Horizon Pharma Option Alert: Jan, 2019 $13 Calls Sweep (9) at the Ask: 541 @ $4.101 vs 327 OI; Ref=$14.48",2017-12-05 13:39:00-05:00,HZNP,positive
642177.0,"Horizon Pharma Names Shao-Lee Lin R&D, Chief Scientific Officer",2017-11-30 06:05:00-05:00,HZNP,neutral
642178.0,31 Stocks Moving In Monday's Mid-Day Session,2017-11-06 12:45:00-05:00,HZNP,neutral
642179.0,Horizon Pharma Says Will Present New KRYSTEXXA Data at ACR/ARHP Meeting: 'Analyses further support the efficacy and safety of KRYSTEXXA',2017-11-06 12:01:00-05:00,HZNP,positive
642180.0,30 Stocks Moving In Monday's Pre-Market Session,2017-11-06 08:06:00-05:00,HZNP,neutral
642181.0,Horizon Pharma Raises FY17 Adj. EBITDA Guidance To $350M-$375M,2017-11-06 07:16:00-05:00,HZNP,neutral
642182.0,Horizon Pharma Raises FY17 Outlook From $985M-$1.02B As Of Jun. 23 To $1.03B-$1.05B vs $1.04B Est.,2017-11-06 07:16:00-05:00,HZNP,neutral
642183.0,"Horizon Pharma Reports Q3 Adj. EBITDA $108.1M, Adj. EPS $0.26 vs $0.22 Est., Sales $271.6M vs $259.7M Est.",2017-11-06 07:15:00-05:00,HZNP,neutral
642184.0,Horizon Pharma Presents Promising Results from Open-Label Study on the Use of PROCYSBI Delayed-Release Capsules in Treatment-NaÃ¯ve Children Younger than 6 Years of Age at #ASN2017,2017-11-05 07:40:00-05:00,HZNP,positive
642185.0,Horizon Pharma Pops to High of $14.08 off of Multiple Call Sweeps,2017-11-01 12:37:00-04:00,HZNP,neutral
642186.0,Horizon Pharma Option Alert: Nov 17 $13 Calls Sweep (42) at the Ask: 1606 @ $1.399 vs 1484 OI; Ref=$13.85,2017-11-01 12:34:00-04:00,HZNP,positive
642187.0,Horizon Pharma Reports First Patient Enrolled In Confirmatory Phase 3 Trial Evaluating Teprotumumab For Treatment Of Moderate-To-Severe Active Thyroid Eye Disease,2017-10-25 08:14:00-04:00,HZNP,positive
642188.0,"Goldman Sachs Initiates Coverage On Horizon Pharma plc - common stock with Buy Rating, Announces $16.00 Price Target",2017-09-28 07:52:00-04:00,HZNP,neutral
642189.0,Horizon Shares Down 4.9% On Lupin vs Horizon Ravicti '559 Patent IPR Final Written Decision,2017-09-26 14:08:00-04:00,HZNP,positive
642190.0,Horizon Pharma Option Alert: Nov 17 $14 Calls Sweep (8) at the Ask: 740 @ $0.6 vs 295 OI; Ref=$12.24,2017-09-15 15:55:00-04:00,HZNP,positive
642191.0,Hearing Horizon Pharma Considering Sale Of Its Primary Care Unit,2017-09-15 15:46:00-04:00,HZNP,positive
642192.0,Watch These 6 Huge Put Purchases In Thursday Trade,2017-09-14 04:45:00-04:00,HZNP,positive
642193.0,Benzinga's Option Alert Recap From September 13,2017-09-13 16:08:00-04:00,HZNP,positive
642194.0,Horizon Pharma Option Alert: Fri $14 Puts Sweep (41) at the Ask: 1000 @ $1.069 vs 279 OI; Ref=$12.96,2017-09-13 10:52:00-04:00,HZNP,positive
642195.0,"13F From Farallon Capital Shows Reduced Stakes In Horzion Pharma, IHS Markit",2017-08-14 13:57:00-04:00,HZNP,neutral
642196.0,18 Biggest Mid-Day Gainers For Monday,2017-08-07 12:33:00-04:00,HZNP,neutral
642197.0,Horizon Pharma Surrenders Some Early Gains After Q2 Beat And Raise,2017-08-07 11:24:00-04:00,HZNP,positive
642198.0,Horizon Pharma Raises FY 2017 Guidance to $1.01B-$1.045B from $985M-1.02B vs $991.2M Est.,2017-08-07 07:04:00-04:00,HZNP,neutral
642199.0,"Horizon Pharma Q2 EPS $0.41 vs $0.10 Est., Sales $289.5M vs $237.0M Est.",2017-08-07 07:03:00-04:00,HZNP,neutral
642200.0,"Earnings Scheduled For August 7, 2017",2017-08-07 05:03:00-04:00,HZNP,neutral
642201.0,Watch These 7 Huge Call Purchases In Thursday Trade,2017-07-13 04:21:00-04:00,HZNP,positive
642202.0,Benzinga's Option Alert Recap From July 12,2017-07-12 16:18:00-04:00,HZNP,positive
642203.0,Horizon Pharma Option Alert: Aug 18 $11 Calls Sweep (31) at the Ask: 1270 @ $2.15 vs 792 OI; Ref=$12.79,2017-07-12 11:32:00-04:00,HZNP,positive
642204.0,Horizon Pharma Says a New Jersey Court Upheld Two Patents and Stated That Mylan Would Infringe With At Least 1 Patent with Their Generic Naproxen Products,2017-06-27 07:07:00-04:00,HZNP,neutral
642205.0,UPDATE: Horizon Pharma Now Sees FY17 Sales $985M-$1.02B vs $990.53M Est.,2017-06-23 11:02:00-04:00,HZNP,neutral
642206.0,"Horizon Pharma Completes Sale Of European Rights To PROCYSBI, Sees FY17 Sales Reduced By $15M As A Results",2017-06-23 11:01:00-04:00,HZNP,neutral
642207.0,15 Stocks Moving In Monday's Pre-Market Session,2017-06-19 08:37:00-04:00,HZNP,neutral
642208.0,Horizon Pharma Reports Health Canada Approval Of PROCYSBI For Treatment Of Neophropathic Cystinosis,2017-06-19 08:04:00-04:00,HZNP,positive
642209.0,"Cantor Fitzgerald Initiates Coverage On Horizon Pharma plc - common stock with Overweight Rating, Announces $13.00 Price Target",2017-06-16 06:24:00-04:00,HZNP,negative
642210.0,Horizon Pharma Presents New Data Analyses Showing 'Significant Clinical Benefit' Of KRYSTEXXA,2017-06-14 09:07:00-04:00,HZNP,positive
642213.0,"Wall Street's M&A Chatter From June 6: Valeant-Bausch & Lomb, Albany Molecular, Horizon Pharma",2017-06-07 06:31:00-04:00,HZNP,neutral
642214.0,Horizon Shares Spiking Higher After Betaville Report Of Horizon Pharma Exploring A Sale,2017-06-06 11:37:00-04:00,HZNP,positive
642215.0,Volume Spike in Horizon Pharma,2017-06-06 11:32:00-04:00,HZNP,neutral
642216.0,"Horizon Pharma Adjusts FY17 GAAP Sales Outlook to $985M-$1.02B, Affirms Adj. EBITDA $315M-$350M",2017-05-23 16:12:00-04:00,HZNP,neutral
642217.0,"Horizon Pharma Sees FY17 Sales Related to PROCYSBI, QUINSAIR in EMEA Regions Reduced by ~$15M, Neutral on Adj. EBITDA",2017-05-23 16:09:00-04:00,HZNP,neutral
642218.0,"UPDATE: Terms of Milestone Payments for Horizon Pharma's Sale of PROCYSBI, QUINSAIR Marketing Rights Not Disclosed",2017-05-23 16:08:00-04:00,HZNP,neutral
642219.0,"Horizon Pharma Reports Deal to Sell European Marketing Rights to PROCYSBI Delayed-Release Capsules, QUINSAIR in EMEA to Chiesi for Upfront Payment of $70M",2017-05-23 16:07:00-04:00,HZNP,neutral
642220.0,Nuvo Pharma Reports US District Court for New Jersey Upheld Validity of Horizon Pharma's US Patent Covering Pennsaid 2% w/w,2017-05-15 07:38:00-04:00,HZNP,neutral
642221.0,Horizon Pharma plc Announces District Court Decision to Uphold PENNSAID 2% w/w Patent in Case with Actavis Labs,2017-05-15 07:18:00-04:00,HZNP,neutral
642222.0,5 Biggest Price Target Changes For Tuesday,2017-05-09 10:03:00-04:00,HZNP,neutral
642223.0,"Benzinga's Top Upgrades, Downgrades For May 9, 2017",2017-05-09 09:27:00-04:00,HZNP,positive
642224.0,Mizuho Downgrades Horizon Pharma plc - common stock to Neutral,2017-05-09 07:27:00-04:00,HZNP,neutral
642225.0,Mid-Afternoon Market Update: Petmed Rises On Strong Q1 Results; TherapeuticsMD Shares Plunge,2017-05-08 14:34:00-04:00,HZNP,positive
642226.0,"Martin Shkreli in Facebook Post Says He Likes Horizon Pharma For A Pop, But 'Wouldn't Marry It'; Likes Alexion A Lot On The Pullback",2017-05-08 14:33:00-04:00,HZNP,positive
642227.0,12 Biggest Mid-Day Losers For Monday,2017-05-08 12:40:00-04:00,HZNP,negative
642228.0,Mid-Day Market Update: Horizon Pharma Drops After Q1 Miss; SGOCO Group Shares Surge,2017-05-08 12:07:00-04:00,HZNP,positive
642229.0,"Cowen Out Positive On Horizon, Says Investors Willing To Look Forward Will See Orphan Assets Undervalued, Specialty Products Will Be Managed To Profitability And Sold",2017-05-08 11:50:00-04:00,HZNP,positive
642230.0,Horizon Pharma At 2-Year Low After Q1 Miss,2017-05-08 10:56:00-04:00,HZNP,negative
642231.0,Mid-Morning Market Update: Markets Edge Lower; Tyson Profit Misses Estimates,2017-05-08 10:09:00-04:00,HZNP,negative
642232.0,20 Stocks Moving In Monday's Pre-Market Session,2017-05-08 08:19:00-04:00,HZNP,neutral
642233.0,"Horizon Pharma Lowers FY 2017 Guidance, Sees Sales $1.00B-$1.04B from $1.24B-$1.29B vs $1.26B Est",2017-05-08 07:27:00-04:00,HZNP,negative
642234.0,"Horizon Pharma Q1 EPS $0.21 vs $0.23 Est, Sales $220.9M vs $247.9M Est",2017-05-08 07:25:00-04:00,HZNP,neutral
642235.0,Horizon Pharma to Acquire River Vision for $145M Cash,2017-05-08 06:58:00-04:00,HZNP,positive
642236.0,Horizon Pharma Says FDA Approves Supplemental NDA to Expand the Age Range for RAVICTI,2017-05-01 07:03:00-04:00,HZNP,positive
642237.0,Horizon Pharma plc Reports USPTO Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO,2017-03-30 07:24:00-04:00,HZNP,neutral
642238.0,Benzinga's Option Alert Recap From March 8,2017-03-08 17:51:00-05:00,HZNP,positive
642239.0,Option Alert: Horizon Pharma Apr 17.0 Calls Sweep: 561 @  ASK  $0.35: 561 traded vs 132 OI:  Earnings 5/8 Before Open (est)  $15.04 Ref,2017-03-08 12:14:00-05:00,HZNP,positive
642240.0,"A Peek Into The Markets: U.S. Stock Futures Edge Lower Ahead Of Durable-Goods Orders, Home Sales Data",2017-02-27 07:37:00-05:00,HZNP,negative
642241.0,"Horizon Pharma Sees FY17 Sales $1.24-$1.29B vs. $1.28B Est., Sees FY17 EBITDA $525-$575M",2017-02-27 07:03:00-05:00,HZNP,neutral
642242.0,"Horizon Pharma Reports Q4 Adj. EPS $0.64 vs. $0.51 Est., Sales $310.3M vs. $309M Est.",2017-02-27 07:02:00-05:00,HZNP,neutral
642243.0,Horizon Pharma Spikes to High of $17.25 Following Report Co Won Against Kyle Bass IPR Patent Challenge on  Vimovo '621 Paten,2017-02-21 15:22:00-05:00,HZNP,positive
642244.0,Watch These 8 Huge Call Purchases In Monday Trade,2017-01-30 04:07:00-05:00,HZNP,positive
642245.0,Benzinga's Option Alert Recap From January 27,2017-01-27 16:55:00-05:00,HZNP,positive
642246.0,Option Alert: Horizon Pharma Feb 18.0 Calls Sweep: 1700 @  ASK  $0.248: 2025 traded vs 14k OI:  Earnings 2/27 Before Open (est)  $15.96 Ref,2017-01-27 14:23:00-05:00,HZNP,positive
642247.0,Benzinga's Option Alert Recap From January 24,2017-01-24 17:26:00-05:00,HZNP,positive
642248.0,Option Alert: Horizon Pharma Mar 17.0 Calls: 2000 @  ASK  $1.30: 2010 traded vs 2012 OI:  Earnings 2/27 Before Open (est)  $16.42 Ref,2017-01-24 11:25:00-05:00,HZNP,positive
642249.0,Option Alert: Horizon Pharma Jan 18.0 Calls Sweep: 1095 @  ASK  $0.547: 1505 traded vs 1891 OI:  Earnings 2/27 Before Open (est)  $17.70 Ref,2017-01-10 10:28:00-05:00,HZNP,positive
642250.0,Horizon Pharma Announces U.S. Patent Office Issuance Of Notice Of Allowance With Claims Covering RAVICTI,2016-12-22 16:05:00-05:00,HZNP,neutral
642251.0,Horizon Pharma plc Announces Availability of QUINSAIR in Canada,2016-12-22 07:03:00-05:00,HZNP,neutral
642252.0,Horizon Reports Availability Of Quinsair In Canada For Treatment Of Lung Infections From Cystic Fibrosis,2016-12-22 07:02:00-05:00,HZNP,neutral
642253.0,"JMP Remains Positive On Horizon, Reiterates Market Outperform Rating And $33 PT As Express Scripts Removed Vimovo and Duexis From Their Exclusion Lists",2016-12-16 14:06:00-05:00,HZNP,positive
642254.0,Technical Alert: Horizon Pharma Higher After Mizuho Upgrade,2016-12-16 12:19:00-05:00,HZNP,positive
642255.0,Horizon Pharma Looking To Finish Strong In 2016,2016-12-16 10:59:00-05:00,HZNP,positive
642256.0,"The Market In 5 Minutes: Adobe, Oracle Take The Earnings Stage",2016-12-16 09:15:00-05:00,HZNP,neutral
642257.0,7 Biggest Price Target Changes For Friday,2016-12-16 09:11:00-05:00,HZNP,neutral
642258.0,15 Stocks Moving In Friday's Pre-Market Session,2016-12-16 08:42:00-05:00,HZNP,neutral
642259.0,"Mizuho Upgrades Horizon Pharma plc - common stock to Buy, Raises Target to $25.00",2016-12-16 06:19:00-05:00,HZNP,neutral
642260.0,"BMO Capital Healthcare Conf. Takes Place Today; Presenters Include Neurocrine Biosciences, Ionis Pharmaceuticals, Horizon Pharma, And Intercept Pharmaceuticals",2016-12-14 08:41:00-05:00,HZNP,neutral
642261.0,Benzinga's Top Downgrades,2016-12-09 08:51:00-05:00,HZNP,positive
642262.0,Mizuho Downgrades Horizon Pharma plc to Neutral,2016-12-09 06:38:00-05:00,HZNP,neutral
642263.0,Mid-Afternoon Market Update: Dow Up 75 Points; Lululemon Shares Surge On Earnings Beat,2016-12-08 15:04:00-05:00,HZNP,positive
642264.0,Hearing UBS Saying Weakness On FA News Is A Buying Opportunity,2016-12-08 11:11:00-05:00,HZNP,neutral
642265.0,Mid-Morning Market Update: Markets Edge Lower; Ciena Profit Misses Estimates,2016-12-08 10:19:00-05:00,HZNP,negative
642266.0,15 Stocks Moving In Thursday's Pre-Market Session,2016-12-08 08:24:00-05:00,HZNP,neutral
642267.0,"Horizon Conf. Call, Says Studies Testing Acctimmune In Cancer To Continue As Planned",2016-12-08 08:14:00-05:00,HZNP,negative
642268.0,"Horizon Pharma's Topline Phase 3 ACTIMMUNE Results Didn't Meet Primary, Secondary Endpoint",2016-12-08 07:53:00-05:00,HZNP,neutral
642269.0,Horizon Pharma Shares Open Down ~18%,2016-12-08 07:30:00-05:00,HZNP,positive
642270.0,Horizon Pharma to Resume Trading at 7:30am,2016-12-08 07:06:00-05:00,HZNP,neutral
642271.0,"Horizon Pharma plc Announces Topline Results from Phase 3 Study of  ACTIMMUNE, Did Not Meet Primary & Secondary Endpoint",2016-12-08 07:04:00-05:00,HZNP,neutral
642272.0,Swedish Orphan Biovitrum Says Signs 5-Year Distribution Agreement With Horizon Pharma,2016-12-07 07:24:00-05:00,HZNP,positive
642273.0,Citi: Buy Horizon Pharma,2016-11-28 10:35:00-05:00,HZNP,neutral
642274.0,Citigroup Reinstates Horizon Pharma at Buy,2016-11-28 07:43:00-05:00,HZNP,neutral
642275.0,5 BioPharma Catalysts Expected Around Christmas,2016-11-27 08:56:00-05:00,HZNP,neutral
642276.0,Jefferies London Health Care Conference Continues Today,2016-11-17 10:14:00-05:00,HZNP,positive
642277.0,The Market In 5 Minutes: Stock Futures Boosted By FBI's Latest Clinton News,2016-11-07 09:09:00-05:00,HZNP,positive
642278.0,Horizon Sees FY16 Rev. $1.045-$1.05B vs. Est. $1.03B,2016-11-07 07:03:00-05:00,HZNP,neutral
642279.0,"Horizon Pharma Reports Q3 EPS $0.70 vs. Est. $0.63, Rev. $273.7M vs. Est. $270M",2016-11-07 07:02:00-05:00,HZNP,neutral
642280.0,UPDATE: Doc from Patent Judge Shows 'we determine that Par has not proved by a  preponderance of the evidence that claims 1â12 are unpatentable.',2016-11-03 13:39:00-04:00,HZNP,neutral
642281.0,"Horizon Pharma Shares Up ~$0.15 Over Last min as Traders Passing Around Filing from Patent Judge Related to Par Pharm, Lupin v. Horizon",2016-11-03 13:37:00-04:00,HZNP,positive
642282.0,"Watch Shares Of Horizon Pharma, Mallinckrodt, Endo International, Depomed, In Sympathy To Dow Jones Report of Valeant Selling Salix Unit",2016-11-01 15:54:00-04:00,HZNP,positive
642283.0,Horizon Pharma Spikes to High  of $17.18 on Volume,2016-11-01 15:44:00-04:00,HZNP,neutral
642284.0,UPDATE: Horizon Pharma Affirms FY16 Adj. EBITDA Outlook ~$450M-$460M,2016-10-25 08:43:00-04:00,HZNP,neutral
642285.0,UPDATE: Horizon Pharma Raises FY16 Adj. Sales Outlook to ~$1.045B-$1.05B vs $1.03B Est.,2016-10-25 08:42:00-04:00,HZNP,neutral
642286.0,UPDATE: Horizon Pharma Raises FY16 GAAP Sales Outlook to ~$980M-$985M,2016-10-25 08:42:00-04:00,HZNP,neutral
642287.0,"Horizon Pharma Raises FY16 Sales Outlook, Affirms Adj. EBITDA Outlook Following Raptor Pharma",2016-10-25 08:41:00-04:00,HZNP,neutral
642288.0,Earnings Season On Deck: How Has Q3 Guidance Looked So Far?,2016-10-12 16:06:00-04:00,HZNP,neutral
642289.0,"8-K from Horizon Pharma Shows Expectation for Q3 Adj. Sales $272M-$274M vs $272.4M Est., Adj. EBITDA in $139M-$141M Range",2016-10-11 08:15:00-04:00,HZNP,neutral
642290.0,Rich Ross Shares His Biotech Trades,2016-10-11 06:32:00-04:00,HZNP,positive
642291.0,"Horizon Pharma To Post Double-Digits Returns, Vetr Crowd Believes",2016-09-30 14:24:00-04:00,HZNP,neutral
642292.0,"Horizon Pharma Enters Into Settlement Agreement With Express Scripts, To Pay $65M; 50% Of Installment To Be Paid In Q4, With 25% In The Following Q1, Q2 Quarters Of 2017",2016-09-29 08:18:00-04:00,HZNP,positive
642293.0,"Horizon Pharma plc Gives Update on PBM Formulary Status for Primary Care Medicines, Secures Formulary Status With Prime Therapeutics For Primary Care Medicines",2016-09-29 08:03:00-04:00,HZNP,positive
642294.0,The Drug Price Increase Debate: Separating The Winners From The Losers,2016-09-27 11:23:00-04:00,HZNP,positive
642295.0,Benzinga's Top Downgrades,2016-09-16 09:02:00-04:00,HZNP,positive
642296.0,Cowen & Co. Downgrades Horizon Pharma to Market Perform,2016-09-16 06:18:00-04:00,HZNP,neutral
642297.0,"Benzinga's M&A Chatter for Monday September 12, 2016",2016-09-12 20:03:00-04:00,HZNP,neutral
642298.0,Mid-Afternoon Market Update: Dow Surges Over 200 Points; Geron Shares Tumble,2016-09-12 14:17:00-04:00,HZNP,positive
642299.0,12 Biggest  Mid-Day  Gainers For Monday,2016-09-12 12:28:00-04:00,HZNP,neutral
642300.0,Mid-Day Market Update: American Farmland Gains Following Merger News; RetailMeNot Shares Drop,2016-09-12 12:15:00-04:00,HZNP,positive
642301.0,Shkreli Thinks Raptor Pharmaceutical's Valuation Was Too Low,2016-09-12 11:01:00-04:00,HZNP,negative
642302.0,Mid-Morning Market Update: Markets Rise; Horizon Pharma To Buy Raptor Pharmaceutical For $9/Share,2016-09-12 10:31:00-04:00,HZNP,neutral
642303.0,The Market In 5 Minutes: Hillary Clinton Falls Ill With The Global Stock Markets,2016-09-12 08:55:00-04:00,HZNP,negative
642304.0,10 Stocks Moving In Monday's Pre-Market Session,2016-09-12 08:37:00-04:00,HZNP,neutral
642305.0,Raptor Jumps 20% After Horizon Pharma's $800 Million Takeover Agreement,2016-09-12 08:01:00-04:00,HZNP,positive
642306.0,Raptor Pharmaceutical to Resume at 7:30 AM ET,2016-09-12 07:09:00-04:00,HZNP,neutral
642307.0,Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. For $9/Share Cash; For Implied Equity Value Of ~$800M,2016-09-12 07:01:00-04:00,HZNP,positive
642308.0,Goldman's 7 Favorite Biotech Ideas For 2016,2016-09-07 16:13:00-04:00,HZNP,positive
642309.0,"Horizon Pharma An Attractive Sum-Of-The-Parts Story, Says Goldman",2016-09-07 15:28:00-04:00,HZNP,positive
642310.0,Watch These 7 Huge Call Purchases In Thursday Trade,2016-08-25 03:00:00-04:00,HZNP,positive
642311.0,Option Alert: HZNP Jan17 24.0 Calls: 1500 @  ASK  $3.10: 3002 traded vs 25k OI: $21.19 Ref,2016-08-24 14:48:00-04:00,HZNP,positive
642312.0,Option Alert: HZNP Sep16 23.0 Calls: 3000 @  ASK  $0.90: 3014 traded vs 679 OI: $22.22 Ref,2016-08-17 12:36:00-04:00,HZNP,positive
642313.0,15 Biggest Mid-Day Gainers For Monday,2016-08-08 12:43:00-04:00,HZNP,neutral
642314.0,Benzinga's Volume Movers,2016-08-08 10:44:00-04:00,HZNP,neutral
642315.0,11 Stocks Moving In Monday's Pre-Market Session,2016-08-08 08:26:00-04:00,HZNP,neutral
642316.0,"Horizon Sees FY16 Rev. $1.025-$1.05B vs. Est. $1.01B, Adj. EBITDA $495-$510M",2016-08-08 07:04:00-04:00,HZNP,neutral
642317.0,"Horizon Pharma Reports Q2 Adj. EPS $0.62 vs. Est. $0.50, Rev. $257.4M vs. Est. $234.8M",2016-08-08 07:03:00-04:00,HZNP,neutral
642318.0,"Earnings Scheduled For August 8, 2016",2016-08-08 04:12:00-04:00,HZNP,neutral
642319.0,Option Alert: HZNP Aug16 24.0 Calls Sweep: 1000 @  ASK  $0.35: 1000 traded vs 1044 OI:  Earnings 8/8 Before Open  $19.57 Ref,2016-08-04 12:34:00-04:00,HZNP,positive
642320.0,"Horizon Pharma Says Secured Covered Status for DUEXIS, VIMOVO with CVS/Caremark Beginning January 1, 2017",2016-08-02 07:23:00-04:00,HZNP,positive
642321.0,Watch These 10 Huge Call Purchases In Tuesday Trade,2016-08-02 02:13:00-04:00,HZNP,positive
642322.0,"UPDATE: Horizon Says 'continues to have discussions with Express Scripts and sees a potential pathway, while not guaranteed...'",2016-08-01 15:58:00-04:00,HZNP,neutral
642323.0,"8-K from Horizon Pharma Shows Co. Has Recognized Express Scripts Published Formulary Exclusion List Which Includes DUEXIS, VIMOVO",2016-08-01 15:58:00-04:00,HZNP,negative
642324.0,"Horizon Pharma Shares Plunge Into Negative Territory, Now Down 5%; Traders Attributing Weakness to Concern Two Drugs Might Not Be Included on Express Scripts List of Covered Drugs",2016-08-01 15:17:00-04:00,HZNP,negative
642325.0,Option Alert: HZNP Aug16 20.0 Calls Sweep: 1000 @  ASK  $0.85: 5511 traded vs 15k OI:  Earnings 8/8 Before Open  $17.74 Ref,2016-08-01 15:13:00-04:00,HZNP,positive
642326.0,Horizon Pharma Sells off to Low of $18.62 on Volume,2016-08-01 14:58:00-04:00,HZNP,negative
642327.0,Option Alert: HZNP Aug16 20.0 Calls Sweep: 956 @  ASK  $1.40: 6852 traded vs 2626 OI:  Earnings 8/8 Before Open  $19.68 Ref,2016-07-27 14:04:00-04:00,HZNP,positive
642328.0,The Story Of Horizon Pharma And Morgan Stanley's Upgrade,2016-07-11 12:31:00-04:00,HZNP,neutral
642329.0,"Morgan Stanley Upgrades Horizon Pharma to Equal-weight, Maintains $24.00 PT",2016-07-11 05:59:00-04:00,HZNP,neutral
642330.0,4 Reasons To Own Horizon Pharma Shares,2016-06-29 15:54:00-04:00,HZNP,positive
642331.0,Horizon Pharma Reports Submission of sNDA for RAVICTI Liquid for Expansion of Age Range for Mgmt of Urea Cycle Disorders,2016-06-29 07:03:00-04:00,HZNP,neutral
642332.0,BMO Capital Initiates Coverage on Horizon Pharma at Outperform,2016-06-29 06:26:00-04:00,HZNP,neutral
642333.0,Horizon Pharma Said to Hire Bank of America to Explore Potential Stake Sale -Reuters,2016-06-28 04:20:00-04:00,HZNP,neutral
642334.0,"Goldman Initiates Specialty Pharma At Neutral, Highlights 'A Confluence Of Concerns'",2016-06-06 13:22:00-04:00,HZNP,neutral
642335.0,"Goldman Likes Horizon Pharma's Emerging Orphan Franchise, Starts At Buy",2016-06-06 11:12:00-04:00,HZNP,positive
642336.0,"Goldman Sachs Initiates Coverage on Horizon Pharma at Buy, Announces $24.00 PT",2016-06-06 07:22:00-04:00,HZNP,neutral
642337.0,"FBR Midday Desk Comments Note Biotech Flows Are Beginning To Wane Following ASCO Over Weekend, Says Data Being Met With Aggressive Short Covering",2016-06-01 12:43:00-04:00,HZNP,negative
642338.0,Horizon Pharma Announces USPTO Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO Delayed Release Tablets,2016-06-01 07:05:00-04:00,HZNP,negative
642339.0,"Amid Wage Disparities And Political Concerns Over Jobs, Top CEOs Bring In Beaucoup Incomes",2016-05-19 11:34:00-04:00,HZNP,positive
642340.0,Horizon Pharma Will Buy Global Rights to Interferon Gamma-1b from Boehringer Ingelheim for â¬5M and â¬20M Upon Closing for the Rights,2016-05-19 07:09:00-04:00,HZNP,neutral
642341.0,Horizon Pharma Reverses Earlier Gains Following Patent Litigation Settlement,2016-05-12 10:23:00-04:00,HZNP,positive
642342.0,Horizon Pharma Reports Settlement of PENNSAID 2% w/w Patent Litigation with Teligent,2016-05-12 07:11:00-04:00,HZNP,negative
642343.0,Option Alert: HZNP Aug16 17.0 Calls: 5000 @  ASK  $1.20: 5000 traded vs 445 OI: $14.21 Ref,2016-05-11 11:31:00-04:00,HZNP,positive
642344.0,Horizon Pharma Reports US PTO Issuance of Added Notice of Allowance with Claims Covering KRYSTEXXA,2016-05-11 07:02:00-04:00,HZNP,neutral
642345.0,Horizon Pharma plc Reports the U.S. Patent and Trademark Office Issuance of Additional Notice of Allowance With Claims Covering KRYSTEXXA,2016-05-11 07:00:00-04:00,HZNP,neutral
642346.0,Mid-Afternoon Market Update: Crude Oil Down Over 2.5%; Horizon Pharma Shares Rise Following Earnings Beat,2016-05-09 14:42:00-04:00,HZNP,negative
642347.0,Mid-Day Market Update: TETRA Technologies Drops Following Weak Results; Krispy Kreme Shares Spike Higher,2016-05-09 12:32:00-04:00,HZNP,negative
642348.0,Mid-Morning Market Update: Markets Edge Higher; Tyson Foods Tops Q2 Estimates,2016-05-09 09:55:00-04:00,HZNP,positive
642349.0,10 Stocks Moving In Monday's Pre-Market Session,2016-05-09 08:33:00-04:00,HZNP,neutral
642350.0,Horizon Pharma Sees FY16 Rev. $1.02-$1.05B vs. Est. $1.00B,2016-05-09 07:03:00-04:00,HZNP,neutral
642351.0,"Horizon Pharma Reports Q1 EPS $0.34 vs. Est. $0.30, Rev. $204.7M vs. Est. $197.7M",2016-05-09 07:02:00-04:00,HZNP,neutral
642352.0,Horizon Pharma plc Completes Target Enrollment of 90 Patients for Phase 3 Trial of ACTIMMUNE(R) (interferon gamma-1b) for the Treatment of People With Friedreich's Ataxia,2016-05-05 08:40:00-04:00,HZNP,neutral
642353.0,"Starboard's Smith Says Depomed Did Not Engage With Horizon Pharma, Took Highly Aggressive 10% Poison Pill",2016-05-04 14:06:00-04:00,HZNP,negative
642354.0,Ira Sohn Conference 2016: The Live Blog,2016-05-04 11:52:00-04:00,HZNP,neutral
642355.0,"Jim Cramer Gives His Opinion On Horizon Pharma, Lululemon And Harley-Davidson",2016-04-27 06:26:00-04:00,HZNP,neutral
642356.0,"Horizon Pharma Announces Settlement with Patient for Pennsaid, Horizon Can Make Generic",2016-04-25 07:01:00-04:00,HZNP,neutral
642357.0,Horizon Pharma Starts To Recover; Vetr Crowd Upgrades Stock,2016-04-13 14:02:00-04:00,HZNP,neutral
642358.0,Mid-Afternoon Market Update: Crude Oil Up 4.5%; Horizon Pharma Shares Tumble,2016-04-12 14:35:00-04:00,HZNP,negative
642359.0,This Explains Horizon Pharma's 25% Plunge,2016-04-12 14:00:00-04:00,HZNP,neutral
642360.0,Mid-Day Market Update: Dow Jumps 150 Points; Juniper Shares Drop On Weak Forecast,2016-04-12 12:12:00-04:00,HZNP,negative
642361.0,"Horizon Pharma Shares Trading Down $3.72 At $14.49/Share, Falling 20% In Morning Trading",2016-04-12 10:10:00-04:00,HZNP,positive
642362.0,Mid-Morning Market Update: Markets Open Higher; Alcoa Revenue Misses Views,2016-04-12 09:50:00-04:00,HZNP,negative
642363.0,10 Stocks Moving In Tuesday's Pre-Market Session,2016-04-12 08:30:00-04:00,HZNP,neutral
642364.0,"Horizon Pharma Sees FY16 Rev. $1.025-$1.05B vs. Est. $1.03B, Adj. EBITDA $505-$520M",2016-04-12 08:09:00-04:00,HZNP,neutral
642365.0,Horizon Pharma Requests Approval For 16M Buyback,2016-04-12 08:08:00-04:00,HZNP,positive
642366.0,Horizon Pharma Releases Investor Presentation,2016-04-12 08:04:00-04:00,HZNP,neutral
642367.0,"Disney, Tesla And 6 Other Stocks Moving In Monday's After-Hours Session",2016-04-04 17:10:00-04:00,HZNP,neutral
642368.0,Mid-Day Market Update: Affymetrix Stock Drops; Valeant Shares Spike Higher,2016-03-21 12:08:00-04:00,HZNP,positive
642369.0,Mid-Morning Market Update: Markets Edge Lower; Sherwin-Williams To Buy Valspar For $113/Share,2016-03-21 10:10:00-04:00,HZNP,negative
642370.0,Horizon Pharma Receives Health Canada Approval For RAVICTI Oral Liquid,2016-03-21 07:00:00-04:00,HZNP,positive
642371.0,Shares of Horizon Pharma Selloff to Low of $13.92; May be Attributed to Cautious Bernstein Note,2016-03-18 09:48:00-04:00,HZNP,negative
642372.0,Bernstein Note Out Saying Bernstein Next 'Bad Actor' To Be Targeted After Valeant'; Mentions Horizon and Galderma,2016-03-18 09:48:00-04:00,HZNP,negative
642373.0,Option Alert: HZNP Apr16 14.0 Puts Sweep: 1355 @  ASK  $1.50: 2075 traded vs 534 OI: $14.25 Ref,2016-03-17 12:26:00-04:00,HZNP,positive
642374.0,Mid-Morning Market Update: Markets Mostly Lower; Michaels Tops Q4 Expectations,2016-03-17 10:14:00-04:00,HZNP,positive
642375.0,Option Alert: HZNP May16 17.0 Calls: 10000 @  ASK  $1.75: 12k traded vs 151 OI: $15.31 Ref,2016-03-16 15:46:00-04:00,HZNP,positive
642376.0,Horizon Pharma Reports US PTO Issued Added Notice of Allowance with Claims Covering RAVICTI Oral Liquid,2016-03-16 07:12:00-04:00,HZNP,neutral
642377.0,Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) Delayed Release Tablets,2016-03-14 07:07:00-04:00,HZNP,negative
642379.0,Horizon Pharma Reports US PTO Has Issued Added Notice of Allowance Related to PENNSAID 2% w/w,2016-03-02 07:05:00-05:00,HZNP,neutral
642380.0,"Earnings Recap For February 29: Lumber Liquidators, Taser & More",2016-02-29 16:38:00-05:00,HZNP,neutral
642381.0,Mid-Afternoon Market Update: Stocks Turn Lower; BroadSoft Shares Rise On Earnings Beat,2016-02-29 14:42:00-05:00,HZNP,neutral
642382.0,"Horizon Pharma Defended At UBS, Maintains Buys ANd $39 PT, Says 'weakness creates buying opportunity'",2016-02-29 12:42:00-05:00,HZNP,positive
642383.0,Mid-Day Market Update: US Stocks Gain; United Natural Foods Shares Slide Following Weak Forecast,2016-02-29 12:09:00-05:00,HZNP,positive
642384.0,Mid-Morning Market Update: Markets Mostly Lower; Lumber Liquidators Misses Q4 Estimates,2016-02-29 10:17:00-05:00,HZNP,negative
642385.0,10 Stocks Moving In Monday's Pre-Market Session,2016-02-29 08:25:00-05:00,HZNP,neutral
642386.0,"Horizon Pharma Reports Q4 Adj. EPS $0.63 vs $0.62 Est., Sales $244.5M vs $240.8M ESs.",2016-02-29 07:00:00-05:00,HZNP,neutral
642387.0,"Earnings Scheduled For February 29, 2016",2016-02-29 04:04:00-05:00,HZNP,neutral
642388.0,Horizon Pharma Announces That Health Canada Determines RAVICTI Oral Liquid Is Eligible for Data Protection,2016-02-22 07:08:00-05:00,HZNP,neutral
642389.0,"Pozen, Egalet Could be Potential Partners for Struggling Biotech Companies -Reuters",2016-02-16 04:16:00-05:00,HZNP,negative
642390.0,Horizon Pharma Spikes to High on Volume,2016-02-03 11:31:00-05:00,HZNP,neutral
642391.0,Horizon Pharma Shares Spiking,2016-02-03 11:30:00-05:00,HZNP,positive
642392.0,Benzinga's Top Initiations,2016-01-19 09:55:00-05:00,HZNP,positive
642393.0,"Jefferies Initiates Coverage on Horizon Pharma at Buy, Announces $31.00 PT",2016-01-19 07:24:00-05:00,HZNP,neutral
642394.0,Mid-Morning Market Update: Markets Open Higher; Alcoa Profit Tops Views,2016-01-12 09:57:00-05:00,HZNP,positive
642395.0,Benzinga's Top #PreMarket Gainers,2016-01-12 08:14:00-05:00,HZNP,positive
642396.0,Horizon Pharma Sees FY2016 Sales $1.02B-1.05B vs $998.82M Est,2016-01-12 07:04:00-05:00,HZNP,neutral
642397.0,Here Are The Top Performing Vetr Crowd Members,2016-01-08 16:08:00-05:00,HZNP,positive
642398.0,UPDATE: Horizon Pharma Says US PTO Allowance Represents Fifth US Patent to be Listed in Orange Book for RAVICTI,2016-01-04 07:14:00-05:00,HZNP,neutral
642399.0,Horizon Pharma Shares Indicated Lower; Co. Recently Announces US PTO Issuance of Added Notice of Allowance with Claims Covering RAVICITI Oral Liquid,2016-01-04 07:13:00-05:00,HZNP,neutral
642400.0,Kyle Bass Explains The 'Patent Trolls' Situation In The Pharma Industry,2016-01-02 20:38:00-05:00,HZNP,neutral
642401.0,Option Alert: HZNP Jan16 22.0 Puts Sweep: 2202 @  ASK  $1.45: 2205 traded vs 885 OI: $22.14 Ref,2015-12-31 12:01:00-05:00,HZNP,positive
642402.0,"Goldman Sachs Initiates Coverage on Horizon Pharma at Buy, Announces $29.00 PT",2015-12-17 08:40:00-05:00,HZNP,neutral
642403.0,"Jim Cramer Shares His Thoughts On Horizon Pharma, Ambarella, Intel And Lam Research",2015-12-16 06:37:00-05:00,HZNP,positive
642404.0,"Brean Reiterates Buy On Horizon Pharma, Likes Crealta Deal",2015-12-14 10:40:00-05:00,HZNP,positive
642405.0,"Horizon Pharma, Fox Chase Cancer Center Temple Health Start Phase 1 Study Of ACTIMMUNE In Combo With Nivolumab In Patients With Advanced Solid Tumors",2015-12-14 07:04:00-05:00,HZNP,negative
642406.0,"Horizon Pharma To Acquire Crealta Holdings For $510M Cash, Transactio To Add $70-$80M In Sales",2015-12-11 07:00:00-05:00,HZNP,neutral
642407.0,"Horizon Pharma Halted, News Pending",2015-12-11 06:55:00-05:00,HZNP,neutral
642408.0,Option Alert: HZNP Dec15 21.0 Calls Sweep: 5000 @  ASK  $0.84: 5055 traded vs 1101 OI: $20.39 Ref,2015-12-10 11:06:00-05:00,HZNP,positive
642409.0,What Should Worry You About Horizon Pharma's Long-Term Business,2015-12-03 10:31:00-05:00,HZNP,negative
642410.0,"Morgan Stanley Assumes Horizon Pharma at Underweight, Announces $23.00 PT",2015-12-03 08:22:00-05:00,HZNP,neutral
642411.0,US Stock Futures Edge Higher Ahead Of Economic Data,2015-11-30 07:18:00-05:00,HZNP,neutral
642412.0,Horizon Pharma plc Receives European Commission Approval for RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid for the Treatment of Urea Cycle Disorders in Patients Two Months of Age and Older,2015-11-30 07:02:00-05:00,HZNP,positive
642413.0,Morning Market Losers,2015-11-20 10:06:00-05:00,HZNP,negative
642414.0,Benzinga's Top #PreMarket Losers,2015-11-20 08:17:00-05:00,HZNP,negative
642415.0,Shares of Horizon Pharma Spike Away from $18 Level as Hearing Stifel Issuing Mid-Day Defense on Name,2015-11-11 13:20:00-05:00,HZNP,positive
642416.0,Mid-Day Market Update: Crude Oil Down 2%; Roundy's Shares Gain On Acquisition News,2015-11-11 12:15:00-05:00,HZNP,positive
642417.0,Mid-Morning Market Update: Markets Edge Lower; Macy's Lowers Full-Year Forecast,2015-11-11 10:20:00-05:00,HZNP,negative
642418.0,Morning Market Losers,2015-11-11 10:06:00-05:00,HZNP,negative
642419.0,Benzinga's Top #PreMarket Losers,2015-11-11 08:20:00-05:00,HZNP,negative
642420.0,"Horizon Pharma Responds to Express Scripts Lawsuit, Recent Allegations",2015-11-11 05:48:00-05:00,HZNP,negative
642421.0,Mid-Morning Market Update: Markets Open Lower; Priceline Issues Weak Forecast,2015-11-09 10:19:00-05:00,HZNP,negative
642422.0,Morning Market Gainers,2015-11-09 09:52:00-05:00,HZNP,neutral
642423.0,Benzinga's Top #PreMarket Gainers,2015-11-09 08:18:00-05:00,HZNP,positive
642424.0,"Horizon Pharma Sees FY16 Sales Up 25+% to $950M-$975M vs $886M Est., FY20 Sales $800M-$1b",2015-11-09 07:09:00-05:00,HZNP,neutral
642425.0,Morning Market Gainers,2015-11-06 09:43:00-05:00,HZNP,neutral
642426.0,Option Alert: $HZNP Nov $22 Call Sweep; 1980 Contracts @Ask @$0.45,2015-11-06 09:43:00-05:00,HZNP,positive
642427.0,Benzinga's Top #PreMarket Gainers,2015-11-06 08:09:00-05:00,HZNP,positive
642428.0,"Horizon Pharma +18% Premarket on Strong Earnings, Guidance",2015-11-06 07:33:00-05:00,HZNP,positive
642429.0,Horizon Pharma Raises FY15 Sales Guidance From $660M-$680M To $750M-$760M,2015-11-06 07:01:00-05:00,HZNP,neutral
642430.0,"Horizon Pharma Reports Q3 EPS $0.70 vs. Est. $0.40, Rev. $226.5M vs. Est. $185.74M",2015-11-06 07:00:00-05:00,HZNP,neutral
642431.0,"Earnings Scheduled For November 6, 2015",2015-11-06 04:03:00-05:00,HZNP,neutral
642432.0,"Shares of Horizon Pharma Dip Below $16.75 Resistance Level, Down $0.40+ Over Last Min",2015-11-04 10:29:00-05:00,HZNP,positive
642433.0,Lone Pine To Investors: We Had A Tough Third Quarter,2015-10-28 14:14:00-04:00,HZNP,negative
642434.0,Horizon Pharma plc Reports the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO Delayed Release Tablets,2015-10-27 16:37:00-04:00,HZNP,negative
642435.0,"Horizon Pharma plc Extends Offer to Acquire Depomed, Inc.",2015-10-26 17:43:00-04:00,HZNP,positive
642436.0,Benzinga's Top #PreMarket Losers,2015-10-26 09:43:00-04:00,HZNP,negative
642437.0,"BZ NOTE: Horizon Highlights, ""Horizon does not own or have an ownership stake in any pharmacy and does not possess an option to purchase any pharmacy""",2015-10-22 17:44:00-04:00,HZNP,positive
642438.0,Horizon Pharma Corrects Misinformation in the Marketplace,2015-10-22 17:41:00-04:00,HZNP,negative
642439.0,"FDA Ruling Shakes Up Biotech: Gilead, AbbVie And More",2015-10-22 16:31:00-04:00,HZNP,neutral
642440.0,"Noted Biotech Analyst Doesn't Think Valeant And Horizon Are Frauds, But Did Push A Line",2015-10-22 13:38:00-04:00,HZNP,negative
642441.0,Horizon Pharma Spiking On Volume Following Mention On Bloomberg In Interview With Citron Research Discussing Valeant Pharma And Phantom Pharmacies,2015-10-22 12:46:00-04:00,HZNP,neutral
642442.0,Depomed Validates Horizon Pharma Rejection Offer,2015-10-22 10:59:00-04:00,HZNP,negative
642443.0,Morning Market Losers,2015-10-22 09:59:00-04:00,HZNP,negative
642444.0,"Depomed Comments on Recent Reports Regarding Horizon Pharma's Business Model, Reports Confirms Concerns Raised By Depomed's Board In Rejecting Horizon's Unsolicited Exchange Offer",2015-10-22 08:32:00-04:00,HZNP,negative
642445.0,Benzinga's Top #PreMarket Losers,2015-10-22 08:20:00-04:00,HZNP,negative
642446.0,Horizon Pharma Reports US PTO Issuance of Added Notice of Allowance with Claims Covering PENNSAID 2%,2015-10-22 07:08:00-04:00,HZNP,neutral
642447.0,"Biotech Names Like Horizon, Pacira, Akorn, Shire, Mallinckrodt  Volatile On Citron Report & Subsequent Valeant Pharma. Press Release",2015-10-21 14:14:00-04:00,HZNP,positive
642448.0,Mid-Afternoon Market Update: Hexcel Drops On Earnings Miss; Weight Watchers Shares Spike Higher,2015-10-20 15:12:00-04:00,HZNP,positive
642449.0,Mid-Day Market Update: Weight Watchers Surges Following Barclays Upgrade; Rambus Shares Slide,2015-10-20 12:30:00-04:00,HZNP,positive
642450.0,Morning Market Losers,2015-10-20 09:51:00-04:00,HZNP,negative
642451.0,Benzinga's Top #PreMarket Losers,2015-10-20 08:47:00-04:00,HZNP,negative
642452.0,How To Invest During Biotech's Latest Crisis,2015-10-09 11:25:00-04:00,HZNP,negative
642453.0,Benzinga's Top Initiations,2015-10-09 09:34:00-04:00,HZNP,positive
642454.0,"Mizuho Securities Initiates Coverage on Horizon Pharma at Buy, Announces $32.00 PT",2015-10-09 07:21:00-04:00,HZNP,positive
642455.0,Horizon Pharma Announces Three  Leading Proxy Advisory Firms Recommend Depomed Shareholders Provide Consent FOR Special Meetings Request,2015-10-07 07:10:00-04:00,HZNP,positive
642456.0,Horizon Pharma Announces Settlement of Rayos,2015-10-02 07:01:00-04:00,HZNP,neutral
642457.0,Horizon Pharma Announces ISS Recommends Depomed Holders Provide Consent FOR Two Special Meeting Requests,2015-09-28 07:07:00-04:00,HZNP,positive
642458.0,15 Stocks Moving In Friday's After-Hours Trading,2015-09-25 17:11:00-04:00,HZNP,neutral
642459.0,Horizon Pharma Reports CHMP Opinion for RAVICTI Oral Liquid for Treatment of Urea Cycle Disorders in Patients Greater Than Two Months of Age,2015-09-25 08:05:00-04:00,HZNP,positive
642460.0,Jim Cramer Shares His Thoughts On Horizon Pharma And SUPERVALU,2015-09-25 07:13:00-04:00,HZNP,positive
642461.0,"Stifel Reiterates Horizon Pharma As 'Select List' Pick, Sees 'Buying Opportunity In Multiple Misguided Reactions'",2015-09-23 08:50:00-04:00,HZNP,positive
642462.0,"Stifel Analysts Believe Horizon Pharma. Pressure From PME ""optimization"" And Concern Around Prescription Trends & Drug Pricing in Biopharma. Is Largely Overdone, Reiterates Horizon As Select List Pick; Buy Rating",2015-09-23 07:16:00-04:00,HZNP,negative
642463.0,"Stifel on Horizon Pharma: 'Buying Opportunity in Multiple Misguided Reactions'; Reiterated as 'Select List' Pick, Buy Rating, $45 Price Target",2015-09-23 07:12:00-04:00,HZNP,positive
642464.0,Option Alert: $HZNP Oct $29 Call; 1940 Contracts @Ask @$0.65; Now $25.53,2015-09-22 12:23:00-04:00,HZNP,positive
642465.0,Benzinga's Top Downgrades,2015-09-22 09:45:00-04:00,HZNP,positive
642466.0,Premium No Longer Deserved? Why Brean's Difei Yang Is Downgrading Horizon Pharma,2015-09-22 09:16:00-04:00,HZNP,negative
642467.0,UPDATE: Brean Cuts Horizon Pharma; Firm's Difei Yang Believes 'Premium Valuation in HZNP No Longer Justified',2015-09-22 06:55:00-04:00,HZNP,negative
642468.0,"Brean Capital Downgrades Horizon Pharma to Hold, Removes $40.00 PT",2015-09-22 06:02:00-04:00,HZNP,neutral
642469.0,8-K from Horizon Pharma Shows Co. Entered Settlement Deal Related to Infringement Litigation Against Taro Pharma,2015-09-15 16:12:00-04:00,HZNP,negative
642470.0,Depomed's Board of Directors Rejects Horizon Pharma plc's Unsolicited Exchange Offer,2015-09-14 08:02:00-04:00,HZNP,negative
642471.0,Depomed Issues Statement On Horizon Pharma Unsolicited Exchange Offer,2015-09-08 09:17:00-04:00,HZNP,neutral
642472.0,Horizon Pharma Announces Commencement of Exchance to Acquire Depomed,2015-09-08 07:03:00-04:00,HZNP,neutral
642473.0,"Depomed 8-K Shows Letter Sent To Horizon Pharma, Says Record Date Re: Horizon Request To be Sent Oct 29th",2015-08-31 06:22:00-04:00,HZNP,neutral
642474.0,This Analyst Loves Depomed And Its Nucynta Prescription,2015-08-28 15:28:00-04:00,HZNP,positive
642475.0,Depomed Sent Letter to Horizon Pharma in Connection with Horizon's Requests for Depomed to Set Record Date to Determine Shareholders Entitled to Request  Special Shareholders Meeting,2015-08-21 07:07:00-04:00,HZNP,positive
642476.0,Horizon Pharma plc to Amend Preliminary Solicitation Statement to Include Proposed Nominees for Depomed's Board,2015-08-19 14:05:00-04:00,HZNP,neutral
642477.0,"UPDATE: Depomed Points Out Horizon's Offer Has Current Value Below $31/Share, Less Than Prior Proposal",2015-08-13 14:03:00-04:00,HZNP,positive
642478.0,Depomed Comments On Horizon Pharma Letter,2015-08-13 14:02:00-04:00,HZNP,neutral
642479.0,Horizon Pharma Issues Letter to Depomed: Says Stands by Bid for Shares at $33/Share,2015-08-13 08:35:00-04:00,HZNP,positive
642480.0,Depomed Issues Letter to Horizon Pharma,2015-08-07 06:32:00-04:00,HZNP,neutral
642481.0,"Last Week's Top Hedge Fund Moves: D.E. Shaw, OZ Management & Lone Pine",2015-08-03 10:47:00-04:00,HZNP,negative
642482.0,Depomed to File Complaint Today against Horizon Seeking Injunction to Prevent Horizon from Unlawfully Exploiting Depomed's Highly Confidential Trade Secret Data,2015-08-03 10:13:00-04:00,HZNP,negative
642483.0,"Depomed Rejected Horizon Pharma's Takeout Bid, But Still Trades As If M&A Is Happening",2015-07-30 08:07:00-04:00,HZNP,negative
642484.0,Depomed Rejects Horizon Pharma's Latest Proposal as 'Inadequte',2015-07-29 16:14:00-04:00,HZNP,negative
642485.0,13G from Lone Pine Capital on Horizon Pharma Shows New 5.4% Stake,2015-07-27 16:46:00-04:00,HZNP,negative
642486.0,"Benzinga's M&A Chatter for Tuesday July 21, 2015",2015-07-21 19:17:00-04:00,HZNP,neutral
642487.0,Depomed Confirms Receipt of Unsolictied Proposal From Horizon Pharma,2015-07-21 11:34:00-04:00,HZNP,neutral
642488.0,"Piper Jaffray: Horizon Pharma Still Has Room For Value Creation, Target Hiked To $48",2015-07-21 10:51:00-04:00,HZNP,positive
642489.0,Horizon Pharma Announces Increased Offer for Depomed from $29.25 to $33/Share,2015-07-21 07:04:00-04:00,HZNP,positive
642490.0,Morning Market Gainers,2015-07-20 09:39:00-04:00,HZNP,neutral
642491.0,Benzinga's Top #PreMarket Gainers,2015-07-20 08:08:00-04:00,HZNP,positive
642492.0,Horizon Pharma Expects Q2 Sales $170M to $172M,2015-07-20 07:09:00-04:00,HZNP,neutral
642493.0,"Horzion Pharma Issues Response to Depomed's Adoption of Poison Pill: 'Very Disappointed,' Urging Board to 'Stop Taking Actions to Frustrate the Will of Holders'",2015-07-13 12:53:00-04:00,HZNP,negative
642494.0,New Studies And Research Evaluating Stem Cell Therapy Treatments for Bone Marrow Diseases & Conditions Look to Identify Next-Generation Therapies For New Pre-Clinical and Phase I/II Clinical Trials,2015-07-09 08:30:00-04:00,HZNP,neutral
642495.0,"Horizon Pharma Names Tina Ventura VP, IR",2015-07-09 07:01:00-04:00,HZNP,neutral
642496.0,"Tuesday, Wednesday's Economic Conditions And Major Market Movers: China Continues To Decline, Greece Continues Delay",2015-07-08 16:57:00-04:00,HZNP,negative
642497.0,"Keep an Eye on These Stocks for July 8, 2015",2015-07-08 04:49:00-04:00,HZNP,neutral
642498.0,"Benzinga's M&A Chatter for Tuesday July 7, 2015",2015-07-07 18:23:00-04:00,HZNP,neutral
642499.0,Mid-Afternoon Market Update: A Schulman Slips After Q3 Results; Plug Power Shares Spike Higher,2015-07-07 15:19:00-04:00,HZNP,positive
642500.0,Mid-Day Market Update: Dow Tumbles 150 Points; Advanced Micro Devices Shares Slide On Nasty Guidance,2015-07-07 13:06:00-04:00,HZNP,negative
642501.0,Mid-Morning Market Update: Markets Drop; Horizon Pharma Proposes To Buy Depomed for $29.25/Share,2015-07-07 11:06:00-04:00,HZNP,negative
642502.0,Benzinga's Volume Movers,2015-07-07 10:40:00-04:00,HZNP,neutral
642503.0,Depomed Confirms Receipt Of Unsolicited Proposal From Horizon Pharma For All-Stock Transaction Valued At $29.25/Share,2015-07-07 10:31:00-04:00,HZNP,positive
642504.0,Stocks Hitting 52-Week Highs,2015-07-07 10:27:00-04:00,HZNP,neutral
642505.0,Morning Market Losers,2015-07-07 10:00:00-04:00,HZNP,negative
642506.0,Morning Market Gainers,2015-07-07 09:50:00-04:00,HZNP,neutral
642507.0,Horizon CEO Says We are Offering a Fair Price for Depomed -Reuters,2015-07-07 08:49:00-04:00,HZNP,positive
642508.0,Benzinga's Top #PreMarket Gainers,2015-07-07 08:12:00-04:00,HZNP,positive
642509.0,"UPDATE: Horizon Pharma Acquisition of Depomed is a Proposal to Shareholders, Not Firm Deal",2015-07-07 07:07:00-04:00,HZNP,neutral
642510.0,"Horizon Pharma All Stock Depomed Acquisition Suggests 41.7% Premium, Values Company at $3B",2015-07-07 07:03:00-04:00,HZNP,positive
642511.0,"Horizon Pharma Announces Acquisition of Depomed For $29.25, All Stock",2015-07-07 07:01:00-04:00,HZNP,neutral
642512.0,US Stock Futures Drop Ahead Of Economic Data,2015-07-06 07:16:00-04:00,HZNP,negative
642513.0,Horizon Pharma plc Files Patent Infringement Lawsuits Against Five Companies for Filing Abbreviated New Drug Applications for PENNSAID 2%,2015-07-06 07:01:00-04:00,HZNP,negative
642514.0,Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID,2015-07-02 07:00:00-04:00,HZNP,neutral
642515.0,Benzinga's Top Initiations,2015-06-11 10:04:00-04:00,HZNP,positive
642516.0,Morgan Stanley Initiates Horizon Pharma With Overweight,2015-06-11 09:05:00-04:00,HZNP,negative
642517.0,"Morgan Stanley Initiates Coverage on Horizon Pharma at Overweight, Announces $38.00 PT",2015-06-11 06:53:00-04:00,HZNP,negative
642519.0,Horizon Pharma plc Initiates Phase 3 Trial of ACTIMMUNE(R) (interferon gamma-1b) for the Treatment of People With Friedreich's Ataxia,2015-06-05 07:02:00-04:00,HZNP,neutral
642520.0,Benzinga's Top Initiations,2015-05-22 08:54:00-04:00,HZNP,positive
642521.0,Leerink Swann Initiates Horizon Pharma With Outperform,2015-05-22 08:24:00-04:00,HZNP,neutral
642522.0,"Leerink Swann Initiates Coverage on Horizon Pharma at Outperform, Announces $37.00 PT",2015-05-22 07:09:00-04:00,HZNP,neutral
642523.0,Horizon Pharma Expecting FY15 Sales $590M-$610M vs $538.76M,2015-05-08 07:08:00-04:00,HZNP,neutral
642524.0,"Horizon Pharma Q1 EPS $0.21 vs $0.21 est, Raises FY Guidance to $590m to $610M, Est $538.8M",2015-05-08 07:05:00-04:00,HZNP,neutral
642525.0,Horizon Pharma Announces Settlement of PENNSAID 2% Patent Litigation With Perrigo; Horizon Grants Perrigo Non-Exclusive Right to Market Generic Diclofenac Sodium Topical 2% W/W Solution in US,2015-05-08 06:05:00-04:00,HZNP,positive
642526.0,"Earnings Scheduled For May 8, 2015",2015-05-08 04:48:00-04:00,HZNP,neutral
642527.0,Option Alert: Horizon Pharma May $35 Call; 1000 Contract Trade above Ask @$0.47; Now $30.10,2015-04-27 13:12:00-04:00,HZNP,positive
642528.0,Horizon Pharma Announces USPTO Issue of Added Notice of Allowance with Claims Covering PENNSAID(R) 2%,2015-04-27 07:00:00-04:00,HZNP,neutral
642529.0,Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOS Delayed-Release Tablets,2015-04-22 07:07:00-04:00,HZNP,neutral
642530.0,Stifel Asks: How High Will Horizon Pharma Guidance Go?,2015-04-20 07:12:00-04:00,HZNP,neutral
642531.0,"Horizon Pharma Recieves US Patent, Trademark Office Issuance of Additional Notice of Allowance With Claims Covering PENNSAID 2%",2015-04-17 07:03:00-04:00,HZNP,neutral
642532.0,Horizon Pharma Prices 15.4M Shares at $28.25/Share,2015-04-15 18:53:00-04:00,HZNP,positive
642533.0,Horizon Pharma plc Announces Proposed Public Offering of 12M Ordinary Shares,2015-04-13 16:01:00-04:00,HZNP,positive
642534.0,Stocks Hitting 52-Week Highs,2015-04-10 10:06:00-04:00,HZNP,neutral
642535.0,Morning Market Gainers,2015-04-10 09:42:00-04:00,HZNP,neutral
642536.0,Benzinga's Top #PreMarket Gainers,2015-04-10 08:16:00-04:00,HZNP,positive
642537.0,Horizon Pharma Given FDA Fast Track Designation for ACTIMMUNE in the Treatment of Friedreich's Ataxia,2015-04-10 07:01:00-04:00,HZNP,neutral
642538.0,"Extreme Networks, Citrix And AngioDynamics Lead Thursday's After-Hours Movers",2015-04-09 20:25:00-04:00,HZNP,neutral
642539.0,Cantor Fitzgerald Downgrades Hyperion After Acquisition,2015-03-31 09:37:00-04:00,HZNP,neutral
642540.0,Piper Jaffray Upgrades Horizon Pharma To Overweight,2015-03-31 09:29:00-04:00,HZNP,negative
642541.0,Benzinga's Top Upgrades,2015-03-31 08:29:00-04:00,HZNP,positive
642542.0,Horizon Pharma Shares Rise 3% Premarket Following Several Analyst PT Increases,2015-03-31 08:23:00-04:00,HZNP,positive
642543.0,"Piper Jaffray Upgrades Horizon Pharma to Overweight, Raises PT to $31.00",2015-03-31 05:55:00-04:00,HZNP,negative
642544.0,"Benzinga's M&A Chatter for Monday March 30, 2015",2015-03-30 20:32:00-04:00,HZNP,neutral
642545.0,Benzinga's Volume Movers,2015-03-30 10:55:00-04:00,HZNP,neutral
642546.0,Stocks Hitting 52-Week Highs,2015-03-30 10:45:00-04:00,HZNP,neutral
642547.0,Monday's Merger Mania,2015-03-30 10:27:00-04:00,HZNP,neutral
642548.0,Morning Market Gainers,2015-03-30 09:38:00-04:00,HZNP,neutral
642549.0,Benzinga's Top #PreMarket Gainers,2015-03-30 08:05:00-04:00,HZNP,positive
642551.0,Morning Market Gainers,2015-02-27 09:44:00-05:00,HZNP,neutral
642552.0,Friday's #PreMarket Movers: JC Penney Down Following Q4 Earnings,2015-02-27 09:32:00-05:00,HZNP,neutral
642553.0,Benzinga's Top #PreMarket Gainers,2015-02-27 08:13:00-05:00,HZNP,positive
642554.0,"Horizon Pharma Q4 EPS $0.27 vs $0.22, Revenue $103.8M vs $95.5M",2015-02-27 07:02:00-05:00,HZNP,neutral
642555.0,"Earnings Scheduled For February 27, 2015",2015-02-27 05:14:00-05:00,HZNP,neutral
642556.0,Horizon Pharma Opens Chicago Office,2015-02-17 08:03:00-05:00,HZNP,neutral
642557.0,Horizon Pharma plc Submits NDA For ACTIMMUNE,2015-02-13 08:02:00-05:00,HZNP,neutral
642558.0,JMP Securities Covers Mostly Good News From Pharma Pending More Visibility,2015-02-11 07:54:00-05:00,HZNP,positive
642559.0,POZEN Announces Issuance of VIMOVO Related Patent by USPTO,2015-02-04 16:34:00-05:00,HZNP,neutral
642560.0,POZEN Announces Issuance of VIMOVO Related Patent,2015-02-04 16:23:00-05:00,HZNP,neutral
642561.0,Horizon Pharma plc Announces Issuance of VIMOVO Related Patent,2015-02-04 16:22:00-05:00,HZNP,neutral
642562.0,"Horizon Pharma Offers Business Update: Reports Accelerated Expansion of PME(TM) Program, Launch of PENNSAID(R)2% in US; Secures Deal with FDA on ACTIMMUNE Phase 3 Trial Primary Endpoint",2015-01-12 08:08:00-05:00,HZNP,positive
642563.0,Horizon Pharma Reports Filing of Patent Infringement Suit Against Watson Labs for Filing ANDA Against PENNSAID(R) 2%,2014-12-24 13:03:00-05:00,HZNP,negative
642564.0,Horizon Pharma Exec Currently Speaking on Webcast for Piper Jaffray Conference: Affirms FY15 Sales Outlook,2014-12-03 13:50:00-05:00,HZNP,neutral
642565.0,Horizon Pharma plc Announces Presentation Of Data Showing Unmet Need In Rheumatoid Arthritis And The Positive Effect of RAYOS,2014-11-18 16:09:00-05:00,HZNP,positive
642566.0,Horizon Pharma Announces Pricing Of 11.6M Secondary Offering At $12.05/share,2014-11-14 08:05:00-05:00,HZNP,neutral
642567.0,Horizon Pharma Announces 11.6M Proposed Secondary Offering of Ordinary Shares by Selling Shareholders,2014-11-13 07:04:00-05:00,HZNP,positive
642568.0,Horizon Pharma plc Announces Favorable Markman Ruling in RAYOS(R) (prednisone) Delayed-Release Tablets Patent Infringement Litigation,2014-11-12 08:07:00-05:00,HZNP,negative
642569.0,Horizon Pharma Shares Rise 7.5% Premarket Following Strong Earnings Report,2014-11-06 07:55:00-05:00,HZNP,positive
642570.0,"Horizon Pharma, Inc. Reports Q3 EPS of $0.24 vs $0.17 Est; Revenue of $75.10M vs $73.17M Est",2014-11-06 07:09:00-05:00,HZNP,neutral
642571.0,POZEN Announces Receipt Of Three Patents From The United States Patent And Trademark Office,2014-10-23 07:30:00-04:00,HZNP,positive
642572.0,Horizon Pharma plc Announces Acquisition of U.S. Rights to PENNSAID ,2014-10-17 07:02:00-04:00,HZNP,neutral
642573.0,Horizon Pharma plc Hosting Conference Tonight to Discuss Opportunities For ACTIMMUNE,2014-10-13 17:01:00-04:00,HZNP,positive
642574.0,"Horzion Pharma Presents Results of ACTIMMUNE(R) Phase 2 Data, Says Results Show Statistical Significant",2014-10-09 13:39:00-04:00,HZNP,positive
642575.0,Horizon Pharma plc Receives Orphan-Drug Designation for ACTIMMUNE ,2014-10-03 16:00:00-04:00,HZNP,neutral
642576.0,Horizon Pharma Announces the U.S. Patent and Trademark Office Issuance ,2014-10-01 08:03:00-04:00,HZNP,neutral
642577.0,"Horizon Pharma Reports Formation of Exec Committee; Todd Smith Resigns as Exec VP, Chief Commercial Officer",2014-09-26 09:05:00-04:00,HZNP,negative
642578.0,"Shares of Horizon Pharma Resume Trade, Now Up ~6%",2014-09-19 11:15:00-04:00,HZNP,positive
642579.0,"Horizon Pharma Reports Closing of Vidara Purchase; Reaffirms FY14, FY15 Outlook",2014-09-19 10:46:00-04:00,HZNP,neutral
642580.0,"Hearing Avondale Initiates Horizon Pharma with $22 PT, Outperform Rating",2014-09-09 10:08:00-04:00,HZNP,neutral
642581.0,Horizon Pharma Announces Notice Of Allowance For U.S. Patent,2014-08-27 07:31:00-04:00,HZNP,neutral
642582.0,Horizon Pharma Offers Update on Effectiveness of S-4 Registration,2014-08-08 07:32:00-04:00,HZNP,neutral
642583.0,Morning Market Movers ,2014-08-07 09:44:00-04:00,HZNP,neutral
642584.0,Benzinga's Top #PreMarket Gainers,2014-08-07 08:08:00-04:00,HZNP,positive
642585.0,"Horizon Pharma, Inc. Reports Q2 EPS of $0.21 Which May Not Compare $0.10 Est; Revenue of $66.10M Which May Not Compare $58.35M Est",2014-08-07 06:32:00-04:00,HZNP,neutral
642586.0,Horizon Pharma Spikes Higher,2014-08-05 14:33:00-04:00,HZNP,neutral
642587.0,Horizon Pharma Announces Two Notices of Allowance From USPTO,2014-08-05 07:30:00-04:00,HZNP,neutral
642588.0,Horizon Pharma Shares Move Higher on Volume,2014-07-30 09:53:00-04:00,HZNP,positive
642589.0,Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties,2014-07-29 16:37:00-04:00,HZNP,negative
642590.0,Morning Market Losers ,2014-07-29 09:54:00-04:00,HZNP,negative
642591.0,"Piper Jaffray Downgrades Horizon Pharma, Inc. to Neutral, Lowers PT to $9.00",2014-07-29 06:53:00-04:00,HZNP,negative
642592.0,Markets Little Changed Ahead Of The Federal Reserve's Policy Decision,2014-07-28 16:36:00-04:00,HZNP,neutral
642593.0,Morning Market Losers ,2014-07-28 09:48:00-04:00,HZNP,negative
642594.0,Benzinga's Top #PreMarket Losers,2014-07-28 08:19:00-04:00,HZNP,negative
642595.0,"Horizon Pharma Announces CVS Caremark, Express Scripts Expect to Announce DUEXIS, VIMOVO Will No Longer be on Formularies; Will be Placed on Exclusion Lists Effective January 1, 2015",2014-07-28 07:37:00-04:00,HZNP,negative
642596.0,Horizon Pharma Shares Move Lower; May be Attributed to Seeking Alpha Post,2014-07-23 12:05:00-04:00,HZNP,neutral
642597.0,"Horizon Pharma Announces CFO Stepping Down, Replaced With Paul Hoelscher",2014-06-18 07:04:00-04:00,HZNP,neutral
642598.0,Benzinga's Top Initiations,2014-05-30 08:09:00-04:00,HZNP,positive
642599.0,"Guggenheim Securities Initiates Coverage on Horizon Pharma, Inc. at Buy, Announces $31.00 PT",2014-05-30 06:22:00-04:00,HZNP,positive
642600.0,Benzinga's Top #PreMarket Gainers,2014-05-09 08:14:00-04:00,HZNP,positive
642601.0,Horizon Pharma Sees FY2014 Sales $270.0M-280.0M vs $260.37M Est,2014-05-09 06:39:00-04:00,HZNP,neutral
642602.0,Horizon Pharma Reports Q1 Adjusted EPS of $0.13 vs $0.01 Est,2014-05-09 06:32:00-04:00,HZNP,neutral
642603.0,"Earnings Scheduled For May 9, 2014",2014-05-09 05:18:00-04:00,HZNP,neutral
642604.0,Horizon Pharma Reports Inducement Grants,2014-04-23 16:36:00-04:00,HZNP,positive
642605.0,Horizon Pharma Announces Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Vidara Therapeutics International Ltd ,2014-04-16 07:31:00-04:00,HZNP,neutral
642606.0,"Option Alert: Horizon Pharma May $13 Call; 5,000 Contract Trade at Ask @$1.55; Currently $12.55; OI is 167",2014-04-11 10:25:00-04:00,HZNP,positive
642607.0,Horizon Pharma Reports US PTO Issued Added Notice of Allowance with Claims Covering RAYOS,2014-04-10 07:31:00-04:00,HZNP,neutral
642608.0,Mid-Afternoon Market Update: Markets Go Red as Anadarko Rallies on Settlement with US,2014-04-03 15:45:00-04:00,HZNP,neutral
642609.0,Mid-Day Market Update: US Stocks Fall; Google Shares Rise After Stock Split,2014-04-03 12:41:00-04:00,HZNP,positive
642610.0,Horizon Pharma Shares Not Affected Following 13D from Vidara Therapeutics Shows 17.6% Stake,2014-03-28 14:35:00-04:00,HZNP,positive
642611.0,Market Wrap For March 19: Yellen Hints of Higher Rates & Sooner Than Expected End To Taper,2014-03-19 18:03:00-04:00,HZNP,neutral
642612.0,"Benzinga's M&A Chatter for Wednesday March 19, 2014",2014-03-19 17:54:00-04:00,HZNP,neutral
642613.0,Amended 13D Filing from Discovery Group on Horizon Pharma Shows 4.8% Stake,2014-03-19 16:42:00-04:00,HZNP,neutral
642614.0,Mid-Afternoon Market Update: Markets Drop Sharply During Janet Yellen's First Conference,2014-03-19 16:19:00-04:00,HZNP,negative
642615.0,"Afternoon Movers for Wednesday, March 19th 2014",2014-03-19 15:54:00-04:00,HZNP,neutral
642616.0,Mid-Day Market Update: Oracle Shares Decline On Weak Results; Horizon Pharma Jumps,2014-03-19 12:04:00-04:00,HZNP,negative
642617.0,Top Trending Tickers On StockTwits For March 19,2014-03-19 10:52:00-04:00,HZNP,positive
642618.0,Mid-Morning Market Update: Markets Edge Higher; FedEx Profit Misses Estimates,2014-03-19 10:12:00-04:00,HZNP,positive
642619.0,Stocks Hitting 52-Week Highs,2014-03-19 10:12:00-04:00,HZNP,neutral
642620.0,Morning Market Movers ,2014-03-19 09:36:00-04:00,HZNP,neutral
642621.0,Benzinga's Top #PreMarket Gainers,2014-03-19 08:07:00-04:00,HZNP,positive
642622.0,Shares of Horizon Pharma Resume Trade Up 12.5%,2014-03-19 07:32:00-04:00,HZNP,positive
642623.0,Adam Feuerstein tweets: '$HZNP is your latest spec pharma to ride the magical leprechaun rainbow to Ireland. Buying a tax haven (Vidara Therapeutics) for $660M.',2014-03-19 07:15:00-04:00,HZNP,neutral
642624.0,"UPDATE: Horizon Pharma Announces the Purchase of Vidara Therapeutics for $660M in Stock, Cash",2014-03-19 07:13:00-04:00,HZNP,neutral
642625.0,Shares of Horizon Pharma to Resume Trade at 7:30AM EDT,2014-03-19 07:07:00-04:00,HZNP,positive
642626.0,"Horizon Pharma Shares Were Halted to Announce the Purchase of Vidara Therapeutics for $660M in Stock, Cash",2014-03-19 07:07:00-04:00,HZNP,positive
642627.0,Morning Market Losers ,2014-03-13 09:50:00-04:00,HZNP,negative
642628.0,Benzinga's Top #PreMarket Losers,2014-03-13 08:15:00-04:00,HZNP,negative
642629.0,Horizon Pharma Reports Q4 Adjusted EPS of $(0.04) vs $(0.08) Est; Revenue of $30.10M vs $32.18M Est,2014-03-13 06:35:00-04:00,HZNP,neutral
642630.0,"Earnings Scheduled For March 13, 2014",2014-03-13 04:51:00-04:00,HZNP,neutral
642631.0,"Perion Network,	 Horizon Pharma, Manitex, Attunity, Galena Biopharma, Concert Pharmaceuticals, Spansion, Magellan Petroleum,	JAKKS Pacific Presenting at Roth Conference at 12:00 PM ET",2014-03-10 12:08:00-04:00,HZNP,neutral
642632.0,Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) ,2014-03-06 07:30:00-05:00,HZNP,positive
642633.0,UPDATE: Horizon Pharma Shares Turn Positive as Piper Jaffray Boosts Target from $17 to $21 in Mid-Day Research Note,2014-03-05 11:10:00-05:00,HZNP,positive
642634.0,Hearing Piper Raises PT on Horizon Pharma to $21; Shares Spike Higher,2014-03-05 11:07:00-05:00,HZNP,positive
642635.0,Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer ,2014-03-05 07:30:00-05:00,HZNP,neutral
642636.0,Amended 13D Filing from Discovery Group on Horizon Pharma Shows 6.3% Stake,2014-03-03 17:24:00-05:00,HZNP,neutral
642637.0,Horizon Pharma IR Says Nothing Reported by Company Causing the Strength in Share Price; May be Attributed to Actavis Acquisition of Forest Labs,2014-02-18 13:46:00-05:00,HZNP,positive
642638.0,Horizon Pharma Spikes Higher,2014-02-18 11:36:00-05:00,HZNP,neutral
642639.0,Horizon Pharma Issues Update on Feb. 10-11th FDA Joint Panel Meeting on CV Risk of NSAIDs,2014-02-11 16:43:00-05:00,HZNP,negative
642640.0,"Option Alert: Horizon Pharma Jan 2015 $10 Call; 5,000 Contract Trade Between Bid and Ask @$1.80; Currently $8.70",2014-01-21 10:45:00-05:00,HZNP,positive
642641.0,"Horizon Pharma January 2015 Call; 4,050 Contract Trade Between Bid and Ask @$1.75; Currently $8.83",2014-01-08 13:47:00-05:00,HZNP,neutral
642642.0,Horizon Pharma Reports Availability of Vimovo(R) in US,2014-01-02 07:33:00-05:00,HZNP,neutral
642643.0,Horizon Pharma Announces Par Pharmaceutical to withdraw ANDA with FDA for a Generic Version of RAYOS Containing 2 mg and 5 mg of Prednisone -8K,2013-11-22 08:08:00-05:00,HZNP,neutral
642644.0,"Market Wrap For November 21: Dow Re-Claims 16,000 level On Positive Job Data",2013-11-21 16:40:00-05:00,HZNP,positive
642645.0,Stocks Hitting 52-Week Highs,2013-11-19 10:55:00-05:00,HZNP,neutral
642646.0,Morning Market Movers ,2013-11-19 10:30:00-05:00,HZNP,neutral
642647.0,Benzinga's Top #PreMarket Gainers,2013-11-19 08:16:00-05:00,HZNP,positive
642648.0,Horizon Pharma Announces Pricing of $150M of 5.00% Convertible Senior Notes ,2013-11-19 07:13:00-05:00,HZNP,neutral
642649.0,Horizon to Acquire US Rights for VIMOVO from Pozen,2013-11-19 06:18:00-05:00,HZNP,neutral
642650.0,"Horizon Pharma, Mundipharma Report Exclusive Deal to Commercialize LODOTRA in Mid East, Africa",2013-11-11 07:31:00-05:00,HZNP,positive
642651.0,Benzinga's Top #PreMarket Gainers,2013-11-08 08:08:00-05:00,HZNP,positive
642652.0,Horizon Pharma Reports Q3 EPS of $(0.03) Which May Not Compare $(0.25) Est; Revenue of $26.22M Which May Not Compare $18.31M Est,2013-11-08 06:44:00-05:00,HZNP,neutral
642653.0,Form 8-K from Horizon Pharma Shows Co. Jagotec Have Filed Suit on Generic Rayos vs Par Pharma,2013-10-23 15:35:00-04:00,HZNP,neutral
642654.0,Benzinga's Top Pre-Market Gainers,2013-10-21 08:10:00-04:00,HZNP,positive
642655.0,Horizon Pharma Reports Clinical Data on RAYOS Tablets Which Will Be Presented at American College of Rheumatology Annual Meeting,2013-10-21 07:35:00-04:00,HZNP,neutral
642656.0,Benzinga's Top Upgrades,2013-10-21 07:32:00-04:00,HZNP,positive
642657.0,"Piper Jaffray Upgrades Horizon Pharma, Inc. to Overweight, Raises PT to $7.00",2013-10-21 06:19:00-04:00,HZNP,negative
642658.0,Horizon Pharma Reports Sanofi Compiegne as Added Manufacturing Site for DUEXIS,2013-09-05 07:34:00-04:00,HZNP,neutral
642659.0,Horizon Pharma Files Patent Infringement Suit vs. Watson Labs Related to ANDA,2013-08-27 17:35:00-04:00,HZNP,negative
642660.0,Horizon Pharma Reports Settlement of DUEXIS Patent Litigation with Par Pharma,2013-08-22 07:39:00-04:00,HZNP,negative
642661.0,"Horizon Pharma, Inc. Reports Q2 EPS of $(0.24) vs $(0.32) Est; Revenue of $17.60M vs $16.09M Est",2013-08-09 06:50:00-04:00,HZNP,neutral
642662.0,"Benzinga Market Primer: Monday, May 13",2013-05-13 06:27:00-04:00,HZNP,neutral
642663.0,"Benzinga Market Primer: Friday, May 10",2013-05-10 06:40:00-04:00,HZNP,neutral
642664.0,"Horizon Pharma, Inc. Reports Q1 EPS of $(0.03) vs $(0.35) Est; Revenue of $9.20M vs $9.47M Est",2013-05-10 06:34:00-04:00,HZNP,neutral
642665.0,"Market Wrap for Monday, March 25: Stocks Fall Despite Cyprus Deal",2013-03-25 16:18:00-04:00,HZNP,neutral
642666.0,UPDATE: Piper Jaffray Reiterates Horizon Pharma at Neutral Following Q4 Earnings,2013-03-19 14:52:00-04:00,HZNP,neutral
642667.0,"Horizon Pharma Tops EPS Estimates, Falls Short on Revenue",2013-03-18 11:54:00-04:00,HZNP,positive
642668.0,"Horizon Pharma, Inc. Reports Q4 EPS of $(0.40) vs $(0.47) Est; Revenue of $6.75M vs $7.59M Est",2013-03-18 06:34:00-04:00,HZNP,neutral
642669.0,"Benzinga Market Primer, Monday March 18",2013-03-18 06:22:00-04:00,HZNP,neutral
642670.0,"Earnings Scheduled For March 18, 2013",2013-03-18 04:09:00-04:00,HZNP,neutral
642671.0,"Horizon Pharma Wins Marketing Authorization for DUEXIS from UK Medicines, Healthcare Products Regulatory Agency",2013-03-07 07:32:00-05:00,HZNP,positive
642672.0,"Horizon Pharma Reports Prelim. Q4 Sales $6.7M, Announces Changes to Recognizing Sales on Some Prescriptions",2013-02-11 07:34:00-05:00,HZNP,neutral
642673.0,Benzinga's Top Pre-Market Gainers,2012-12-21 08:24:00-05:00,HZNP,positive
642674.0,Horizon Pharma Commences Initial Commercial Launch of RAYOS(R),2012-12-03 07:59:00-05:00,HZNP,neutral
642675.0,"Earnings Scheduled For November 13, 2012",2012-11-13 02:45:00-05:00,HZNP,neutral
642676.0,Horizon Pharma Spikes Lower,2012-11-08 15:17:00-05:00,HZNP,negative
642677.0,"Stifel Nicolaus Maintains Horizon Pharma at Buy, Lowers PT from $9 to $6",2012-10-16 07:45:00-04:00,HZNP,negative
642678.0,From Earlier: Horizon Pharma Announces US Patent for Rayos Tablet,2012-10-15 09:22:00-04:00,HZNP,neutral
642679.0,Horizon Pharma Announces Receipt of Two Additional U.S. Patent Allowances for DUEXIS,2012-09-28 07:38:00-04:00,HZNP,neutral
642680.0,Morning Market Losers,2012-09-20 13:57:00-04:00,HZNP,negative
642681.0,Horizon Pharma Prices $75 Million Public Offering of Common Stock and Warrants to Purchase Common Stock ,2012-09-20 09:04:00-04:00,HZNP,neutral
642682.0,Horizon Pharma Prices $75M Offering of Stock-Warrants,2012-09-20 09:01:00-04:00,HZNP,neutral
642683.0,"Horizon Pharma Falls 10% Pre-Market on Stock, Warrant Offering",2012-09-20 07:41:00-04:00,HZNP,neutral
642684.0,Horizon Pharma Announces Proposed Public Offering of Common Stock,2012-09-19 16:00:00-04:00,HZNP,neutral
642685.0,Horizon Pharma Enters into Sales Agreement with Cowen and Company,2012-08-14 16:53:00-04:00,HZNP,positive
642686.0,Discovery Group Discloses 7.5% Stake in Horizon Pharma,2012-08-13 16:37:00-04:00,HZNP,neutral
642687.0,UPDATE: Discovery Group May Seek Talks with Horizon Management,2012-08-13 16:31:00-04:00,HZNP,neutral
642688.0,Discovery Group Has 7.5% Stake in Horizon Pharma,2012-08-13 16:30:00-04:00,HZNP,neutral
642689.0,Horizon Pharma Reports Q2 EPS $-0.62 vs $-0.66 Est; Revenues $3.8M vs $4.44M Est,2012-08-10 07:02:00-04:00,HZNP,neutral
642690.0,Horizon Pharma Reports Q2 EPS $-0.68 vs $-0.66 Est; Revenues $3.8M vs $4.44M Est,2012-08-10 07:02:00-04:00,HZNP,neutral
642691.0,Horizon Pharma Announces Second Quarter 2012 Financial Results and Provides Business Update  ,2012-08-10 07:01:00-04:00,HZNP,neutral
642692.0,"Earnings Scheduled For August 10, 2012",2012-08-10 03:18:00-04:00,HZNP,neutral
642693.0,Horizon Pharma Files Mixed-Securities Shelf for up to $175 Million,2012-08-01 09:24:00-04:00,HZNP,neutral
642694.0,"Option Alert: Horizon Pharma Call Volume at 2,000% of Average; Currently $6.27",2012-07-27 10:02:00-04:00,HZNP,positive
642695.0,Horizon Pharma Updates Filing,2012-07-26 16:57:00-04:00,HZNP,neutral
642696.0,Horizon Pharma Resumes Trading,2012-07-26 16:40:00-04:00,HZNP,neutral
642697.0,PREVIEW: Horizon Pharma to Resume at 4:40pm,2012-07-26 16:15:00-04:00,HZNP,neutral
642698.0,Horizon's Rayos Gets FDA Approval,2012-07-26 16:13:00-04:00,HZNP,positive
642699.0,Horizon Pharma Announces FDA Approval of RAYOS Delayed-Release Tablets for Rheumatoid Arthritis and Multiple Additional Indications ,2012-07-26 16:11:00-04:00,HZNP,positive
642700.0,Horizon Pharma Halted Pending News,2012-07-26 15:40:00-04:00,HZNP,neutral
642701.0,Horizon Pharma Falls 5% Pre-Market on Martin Shkreli Tweet,2012-07-26 08:03:00-04:00,HZNP,neutral
642702.0,Horizon's Rayos FDA Approval Thursday Seems Likely -Adam F Tweet,2012-07-25 10:24:00-04:00,HZNP,positive
642703.0,Horizon Pharma Spiking Higher,2012-07-24 08:21:00-04:00,HZNP,neutral
642704.0,Amarin and Horizon Pharma Higher Ahead of PDUFA Dates,2012-07-23 15:06:00-04:00,HZNP,neutral
642705.0,Biotechs With Upcoming PDUFA Dates,2012-07-18 15:09:00-04:00,HZNP,neutral
642706.0,Option Alert: Horizon Pharma Call Volume at 1001% of Average; Currently $7.22,2012-07-10 10:32:00-04:00,HZNP,positive
642707.0,Spokesperson for Horizon Pharma Cites Recent Marketing Agreement Announcements for DUEXIS for the US and Latin America as Cause of Recent Strenth,2012-06-25 15:51:00-04:00,HZNP,positive
642708.0,The GrÃ¼nenthal Group Enters into Exclusive Agreement with Horizon Pharma for Commercialization of DUEXISÂ® in Latin America ,2012-06-19 08:51:00-04:00,HZNP,positive
642709.0,Horizon Pharma Enters into Exclusive Agreement with Grunenthal for Commercialization of DUEXISÂ® in Latin America ,2012-06-19 07:30:00-04:00,HZNP,positive
642710.0,Mallinckrodt Announces Co-Promotion Arrangement for DUEXISÂ®   ,2012-06-18 06:33:00-04:00,HZNP,neutral
642711.0,Horizon Pharma Announces Issuance of U.S. Patent Covering RAYOS (delayed-release prednisone) ,2012-05-29 07:31:00-04:00,HZNP,neutral
642712.0,Horizon Pharma Announces Annals of the Rheumatic Diseases Publishes Pivotal Phase 3 Study Demonstrating Efficacy and Safety of RAYOS in Combination With DMARD Therapy in Rheumatoid Arthritis Patients  ,2012-05-07 07:30:00-04:00,HZNP,positive
642713.0,Horizon Pharma Files Patent Infringement Suit Against Par,2012-03-28 16:30:00-04:00,HZNP,negative
642714.0,Horizon Pharma Enters Into Exclusive Agreement With Mundipharma,2012-03-07 07:03:00-05:00,HZNP,positive
642715.0,Horizon Pharma Announces $50.8M Private Placement  ,2012-02-29 07:06:00-05:00,HZNP,neutral
642716.0,"Horizon Pharma Halted, Pending News",2012-02-29 07:02:00-05:00,HZNP,neutral
642717.0,Horizon Pharma Secures $60 Million Loan Facility  ,2012-02-22 16:52:00-05:00,HZNP,positive
642718.0,From Earlier: Horizon Receives Notice of Paragraph IV Certification Against Patents for DUEXIS,2012-02-17 08:34:00-05:00,HZNP,neutral
642719.0,Horizon Pharma Modifies DUEXIS Marketing Authorization Application to Include Recently Approved Manufacturing Site  ,2012-02-13 08:01:00-05:00,HZNP,positive
642720.0,Horizon Pharma Announces Launch of DUEXIS 800 mg/26.6 mg in the United States  ,2011-12-05 07:01:00-05:00,HZNP,positive
642721.0,Horizon Pharma Announces Launch of DUEXIS 800 mg/26.6 mg in the United States  ,2011-12-05 07:01:00-05:00,HZNP,positive
642722.0,"Financial Breakfast: Morning News Summary for November 29, 2011",2011-11-29 07:35:00-05:00,HZNP,neutral
642723.0,Horizon Pharma Announces U.S. Food and Drug Administration Acceptance of LODOTR,2011-11-29 07:03:00-05:00,HZNP,positive
642724.0,Horizon Pharma Announces U.S. Food and Drug Administration Acceptance of LODOTRA New Drug Application,2011-11-29 07:00:00-05:00,HZNP,positive
642725.0,Horizon Pharma and Sanofi Announce FDA Approval of DUEXIS(R) Commercial Manufacturing Facility  ,2011-11-14 07:00:00-05:00,HZNP,positive
642726.0,Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States  ,2011-10-13 07:30:00-04:00,HZNP,positive
642727.0,Horizon Pharma Adds Two New Biopharmaceutical Executives to Its Board of Directors  ,2011-09-30 07:01:00-04:00,HZNP,neutral
642728.0,Horizon Pharma Submits New Drug Application for LODOTRA for the Treatment of Rheumatoid Arthritis  ,2011-09-28 07:08:00-04:00,HZNP,neutral
642729.0,Horizon Pharma Submits New Drug Application for LODOTRA(R) for the Treatment of Rheumatoid Arthritis  ,2011-09-28 07:02:00-04:00,HZNP,neutral
642730.0,UPDATE: Stifel Nicolaus Initiates Horizon Pharma at Buy,2011-09-07 09:15:00-04:00,HZNP,neutral
642731.0,"Stifel Nicolaus Initiates Horizon Pharma At Buy, $12 PT",2011-09-07 08:06:00-04:00,HZNP,neutral
642732.0,Horizon Pharma Receives U.S. Patent Allowance for DUEXIS,2011-09-06 07:31:00-04:00,HZNP,neutral
642733.0,"Horizon Pharma Reports Q2 EPS ($5.54), Revenue $1.3M",2011-08-31 08:04:00-04:00,HZNP,neutral
642734.0,IPO Horizon Pharma Inc Opens at $9 After Original Pricing at $9/Share,2011-07-28 11:20:00-04:00,HZNP,positive
642735.0,Horizon Pharma Announces Pricing of Its IPO at $9.00 per Share,2011-07-28 10:29:00-04:00,HZNP,positive
